S (2015-2019)

STUDIES ON CONDITIONS and RELATED ARTICLES 2015-2019

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
^Articles/Studies in 2010-2014 List
>Information in Another Section

SAFETY AS A SUBSTANCE*+
SAFETY-ADULTERANTS/CONTAMINANTS*+
SALIVARY GLANDS/SALIVA
>SCHINZEL-GIEDION SYNDROME (See News Articles 2010-2018)
SCHISTOSOMA INFECTION+
SCHIZOPHRENIA/MENTAL DISORDERS*+
SCHWANNOMATOSIS (Genetic Disorder with Multiple Benign Tumors called Schwannomas, which Grow on Peripheral Nerves and the Spinal Cord)
SCIATIC NERVE INJURY

SCLERODERMA/SYSTEMIC SCLEROSIS+
SEBACEOUS GLANDS+ (Produce Skin Oils)
SEBORRHEA
SEPTIC SHOCK/SEPSIS*+
SEXUAL ABUSE

SEXUAL MINORITIES
>SHINGLES (See News Articles 2010-2018)

SICKLE CELL DISEASE+
>SINUSITIS (See also 2000-2009)
SKIN

SLEEP APNEA+
SLEEP DISORDERS/PARASOMNIAS (Sleep Walking, Sleep Paralysis, Night Terrors etc. See also NIGHTMARES)

SLEEPING SICKNESS/TRYPANOSOMIASIS*^ (See Also CHAGAS DISEASE)
SLEEP MODULATION*+
SMALLPOX+ (See Also COW POX [not good news])
SMELL/OLFACTORY SYSTEM/ODOR DETECTION+
SMOKED CANNABIS AS A MEDICATION*+ (See Also METHODS OF USE-SMOKING)
SOCIAL ADJUSTMENT/BEHAVIOR*+
SOCIAL ANXIETY

SOCIAL MEDIA/INTERNET
SPACEFLIGHT/OUTER SPACE
SPASTICITY*+
SPINAL CORD INJURY*+
SPINAL MANIPULATIVE THERAPY

SPINOCEREBELLAR ATAXIA/SCA (Inherited Neurodegenerative Disorder. See Also ATAXIA)
SPLEEN*+
SPORTS (see Also EXERCISE)
STEM CELLS+
STIFF-PERSON SYNDROME/HYPEREKPLEXIA DISEASE+~
STORAGE of CANNABIS/CANNABINOIDS (Most Are Old, But Questions On Storage Come Up Often!)
STRAIN INFORMATION (Until Researchers Pay Attention To What Strains They Are Using, They Will Never Get Consistent Results!)
STRESS+ (See Also ANXIETY, POST TRAUMATIC STRESS DISORDER)
STROKE*+ (See Also PERINATAL HYPOXIC-ISCHEMIC INJURY)
STURGE-WEBER SYNDROME (Causes Vascular Malformations, Epilepsy, Strokes and Retardation)

STUTTERING+ (See Also News Articles 2010-2018)
SUICIDE+
SURFER’S EYE/PTERYGIUM

SYSTEMIC MASTOCYTOSIS
top


SAFETY AS A SUBSTANCE*+
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
top
The cannabis conundrum: Thinking outside the THC box (full–2015) https://www.researchgate.net/publication/274726629_The_cannabis_conundrum_Thinking_outside_the_THC_box_The_Cannabis_Conundrum_Thinking_Outside_the_THC
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product-Colorado, March 2014 (full–2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development (full–2015) http://www.hindawi.com/journals/ecam/2015/238482/
Mull it over: cannabis vaporizers and harm reduction (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Cannabinoids in the management of chronic pain: a front line clinical perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0059/jbcpp-2015-0059.xml
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361312/
Cannabis Allergy: What do We Know Anno 2015 (full–2015) http://link.springer.com/article/10.1007%2Fs00005-015-0352-z
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Responsible and controlled use: Older cannabis users and harm reduction (full–2015) http://www.ijdp.org/article/S0955-3959(15)00075-4/fulltext
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9- tetrahydrocannabinol in older persons with dementia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480847/
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/divclasstitlemarijuana-a-time-honored-but-untested-treatment-forepilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader
Phytocannabinoids and epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Safety of oral dronabinol during opioid withdrawal in humans (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663169/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)  http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A  systematic review of randomized controlled trials (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) (full–2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Half-Baked — The Retail Promotion of Marijuana Edibles (article–2015)  http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
How beneficial is vaping cannabis to respiratory health compared to smoking?  (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context (article–2015) http://www.beyondthebrain.net/blog/peaceful-feeling-or-up-in-smoke-medical-marijuana-in-medicolegal-context
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115574493
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
European rating of drug harms (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/25922421

top
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/nl9g6x6
A safer alternative: Cannabis substitution as harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the
modulation of distinct panic-like responses (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25601395
Medicinal cannabis in Australia: the missing links (full–2016)  https://pdfs.semanticscholar.org/0a78/2bc09cea4e52007a16bd725ec3bee51e80b2.pdf
Merck Manual – Marijuana (Cannabis) Professional version (full–2016) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuanacannabis
Merck Manual – Marijuana (Cannabis) Consumer version (full–2016) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers (full–2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (full–2016) http://www.seizure-journal.com/article/S1059-1311(16)00005-4/fulltext
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Associations Between Cannabis Use and Physical Health Problems in Early Midlife (full–2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to  marijuana? (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in  Electronic Cigarettes (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of  Clinical Effectiveness, Safety, and Guidelines (full–2016)  https://www.ncbi.nlm.nih.gov/books/NBK395789/
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and  Interest Prior to Program Launch (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes  (full–2016) http://www.ijdp.org/article/S0955-3959(16)30334-6/fulltext
Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana (full–2016) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1135158
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders (link to download–2016) http://www.eurekaselect.com/85221/article
Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway (link to PDF–2016)  http://jpet.aspetjournals.org/content/early/2016/05/18/jpet.116.232561.long
Evidence for Medicinal Use of Cannabis (article–2016) http://www.physio-pedia.com/Evidence_for_Medicinal_Use_of_Cannabis
Marijuana – How Safe is it Really? (article-link to PDF–2016)  https://journals.mcmaster.ca/iScientist/article/download/1104/991
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer Beware (full–2016) http://jama.jamanetwork.com/article.aspx?articleid=2526619
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115

Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26757043
Chapter 5 – Quality Control and Stability Assessment (abst–2016)  http://www.sciencedirect.com/science/article/pii/B9780128046463000059
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A
systematic review of randomized controlled studies (abst in German & English-2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y
Plant-Derived and Endogenous Cannabinoids in Epilepsy (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26892745
Cannabinoids: Medical implications (abst–2016)  http://www.tandfonline.com/doi/abs/10.3109/07853890.2016.1145794?journalCode=iann20
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain:  A Prospective Open-label Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26889611
Qualitative research in Spanish cannabis social clubs: “The moment you enter the door,  you are minimising the risks” (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27461986
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst in German & English-2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
State of the evidence: Cannabinoids and cancer pain-A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863159
Could cannabidiol be used as an alternative to antipsychotics? (abst–2016)  http://www.journalofpsychiatricresearch.com/article/S0022-3956(16)30104-2/abstract
Evaluating the public health impacts of legalizing recreational cannabis use in the USA  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27082374
Why it is probably too soon to assess the public health effects of legalisation of  recreational cannabis use in the USA (abst–2016)  http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30071-2/abstract
Attitudes to legalizing cannabis use (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27037958

Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK65755/
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)
http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of
Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care
Setting (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent
Epilepsy? (full–2017) http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
top
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An  Australia-Centered Study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
The current status of artisanal cannabis for the treatment of epilepsy in the United States (full–2017)  https://www.projectcbd.org/sites/projectcbd/files/downloads/the_current_status_of_artisanal_cannabis_for_the_treatment_of_epilepsy_in_the_united_states.pdf
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392943
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions,  Possibilities, and Challenges (full–2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Vaping medical marijuana (full–2017)  http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738750/
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines [Internet] (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29293302
Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A  Systematic Review (full–2017)  https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0098113 /
Efficacy of Medical Cannabis for Treatment of Refractory Epilepsy in Children and  Adolescents with Emphasis on the Israeli Experience (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4041
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome  after Human Papillomavirus Vaccination (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4042
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
A 10-year review of cannabis exposure in children under 3-years of age: do we need a  more global approach? (abst–2017) https://link.springer.com/article/10.1007%2Fs00431-017-2872-5
Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views  Toward Legalization and Knowledge of Potential Harm (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28252456
Can we make cannabis safer? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28259650
Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28355118
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
Marijuana Use in the Elderly: Implications and Considerations (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28595684
Pharmacologic Implications of Marijuana Use During Pregnancy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28599743
A little “dab” will do ya’ in: a case report of neuro-and cardiotoxicity following use of  cannabis concentrates (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28644052
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28696583
Occurrence of illicit drugs in water and wastewater, and their removal during wastewater treatment (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0043135417306413
Is there a role for cannabidiol in psychiatry? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28112021
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
Sativex in the management of multiple sclerosis-related spasticity: An overview of the  last decade of clinical evaluation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29055461
Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29106691
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28537982
Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse  effects in female Swiss mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0273230017304014?via%3Dihub
Practical considerations in medical cannabis administration and dosing (abst–2017)  http://www.ejinme.com/article/S0953-6205(18)30004-9/fulltext
Cannabis Intoxication Case Series: The Dangers of Edibles Containing  Tetrahydrocannabinol (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29103798
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians (full–2018) http://jaoa.org/article.aspx?articleid=2671435
Urgent need for federal investment in research on cannabis health impacts, say
researchers. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798990/
Toxicity, Cannabinoids. (full – 2018) https://www.ncbi.nlm.nih.gov/books/NBK482175/
New York Physicians’ Perspectives and Knowledge of the State Medical Marijuana
Program. (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899285/
An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid
Extract of the Aerial Parts of Hemp. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011091/
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review
From Public Health Prospective. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999798/A Cross-Sectional Study of Cannabidiol Users. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/
Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in
Otolaryngology Patients. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057224/
Personal experience and attitudes of pain medicine specialists in Israel regarding the
medical use of cannabis for chronic pain. (full – 2018)
https://www.dovepress.com/personal-experience-and-attitudes-of-pain-medicine-specialists-in-isra-peer-reviewed-fulltext-article-JPR
Adverse Effects of Cannabis on Male Reproduction. (full – 2018)
https://www.eu-focus.europeanurology.com/article/S2405-4569(18)30225-6/fulltext
Elucidating the Impact of Adolescent Marijuana Use. (full – 2018)
https://www.jahonline.org/article/S1054-139X(18)30238-6/fulltext
Therapeutic Use of medicinal cannabis in difficult to manage epilepsy. (full – 2018)
https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13711
Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in
Treatment-Resistant Epilepsy: Observational Data Meta-analysis. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fneur.2018.00759/full
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (full – 2018)  https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full
Therapeutic potential of medicinal marijuana: an educational primer for health care
professionals. (full – 2018)
https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-articleDHPS
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A
randomized, double-blind, controlled trial. (full – 2018)
https://www.epilepsybehavior.com/article/S1525-5050(18)30483-9/fulltext
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of Marijuana on Cancer Palliation. (full – 2018)
https://cjon.ons.org/cjon/22/1/medical-cannabis-oncology-nurse-s-role-patient-education-about-effects-marijuana-cancer
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into
Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer. (full – 2018)
http://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic
Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects
Relative to Δ9-THC. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.01084/full
Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people. (full – 2018)
https://bmjopen.bmj.com/content/8/11/e021109.long
Examining the Association between the Body Burdens of Harmful Chemicals and the Heaviness of Marijuana Smoking. (full – 2018)
https://pubs.acs.org/doi/10.1021/acs.chemrestox.8b00160
Efficacy of cannabinoids in paediatric epilepsy. (full – 2018)
https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14087
Epilepsy and Cannabis: A Literature Review. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235654/
Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. (full – 2018)
https://jnnp.bmj.com/content/89/7/741.long
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. (full – 2018)
https://www.nejm.org/doi/full/10.1056/NEJMoa1714631
Cannabis in palliative care: current challenges and practical recommendations.
(full – 2018) http://apm.amegroups.com/article/view/20097/21242
Erratum to cannabis in palliative care: current challenges and practical recommendations (erratum – 2018) http://apm.amegroups.com/article/view/23880/23545
Perceptions of plain packaging and health warning labels for cannabis among young
adults: findings from an experimental study. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288865/
Cannabis for peripheral neuropathy: The good, the bad, and the unknown (full–2018) https://www.mdedge.com/ccjm/article/189782/drug-therapy/cannabis-peripheral-neuropathy-good-bad-and-unknown
Cannabinoids and Pain: New Insights From Old Molecules. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/
Weighing the Benefits and Risks of Medical Marijuana Use: A Brief Review (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306710/
The Misclassification of Medical Marijuana. (full – 2018)
http://jaapl.org/content/46/4/472.long
Prospective analysis of safety and efficacy of medical cannabis in large unselected
population of patients with cancer (Israel) (click “researchgate” for download–2018)
https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Practical considerations in medical cannabis administration and dosing (link to PDF–2018)  https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
Medical Cannabis for Older Patients. (link to PDF – 2018)
https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients
Cannabis and Anti-Cancer Drugs: Societal Usage and Expected Pharmacological
Interactions – A Review (download–2018) http://www.ch-thuir.fr/sites/default/files/Bouqui-_et_al-2018-Fundamental_%26_Clinical_Pharmacology.pdf
What really happened after Colorado legalized marijuana? (editorial – 2018)
http://www.cmaj.ca/content/190/41/E1237.long
Peering Through the Haze of Smoked vs Vaporized Cannabis—To Vape or Not to Vape? (article – 2018) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2716984
Safety of cannabidiol prescribed for children with refractory epilepsy. (letter – 2018)
https://www.mja.com.au/journal/2018/209/5/safety-cannabidiol-prescribed-children-refractory-epilepsy
Medical Cannabis and AASM Position Statement: The Don’t Ask, Don’t Tell Wishing
Well. (letter – 2018)
http://jcsm.aasm.org/ViewAbstract.aspx?pid=31418
Stop the Attack on Minnesota’s Courageous Stance to Allow Its Residents to Sleep
Safely. (letter – 2018)
http://jcsm.aasm.org/ViewAbstract.aspx?pid=31419
Medical Cannabis, Synthetic Marijuana Extracts, and Obstructive Sleep Apnea.
(letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31420
Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats.
(1st page – 2018) https://www.vetsmall.theclinics.com/article/S0195-5616(18)30087-1/abstract
Cannabis for the treatment of Crohn’s disease (abst + summary in English & Spanish–2018)  https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/full
A Reciprocal Effects Analysis of Cannabis Use and Perceptions of Risk. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29377544
Intoxication From Accidental Marijuana Ingestion in Pediatric Patients: What May Lie Ahead. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29406477
Regulating Cannabis Manufacturing: Applying Public Health Best Practices from
Tobacco Control (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29438634
An overview of health and safety in the Colorado cannabis industry. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29537065
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/0883073818773028?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Medical cannabis: aligning use to evidence‐based medicine approach. (abst – 2018)
https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13657
Assessing the public health impact of cannabis legalization in Canada: core outcome
indicators towards an ‘index’ for monitoring and evaluation. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29860521
Investigational cannabinoids in seizure disorders, what have we learned thus far?
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29842819
Cannabinoids for Treatment of MS Symptoms: State of the Evidence. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs11910-018-0859-x
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia:
Implications for Pharmacological Intervention. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30022465Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (abst – 2018)
https://www.semanticscholar.org/paper/Risks-and-Benefits-of-Marijuana-Use%3A-A-National-of-KeyhaniSteigerwald/72d1820fcad2d5c86152febf95001935b5e11c56
Monoacylglycerol Lipase Inhibitor is Safe when Combined with Delayed r-tPA
Administration in Treatment of Stroke. (abst – 2018)
https://link.springer.com/article/10.1007/s10753-018-0848-x
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30051617
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut
Syndrome: A Systematic Review and Meta-Analysis. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs40263-018-0558-9
Occupational health and safety in cannabis production: an Australian perspective.
(abst – 2018) https://www.tandfonline.com/doi/abs/10.1080/10773525.2018.1517234?journalCode=yjoh20
Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30291748
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder
and Severe Behavioral Problems—A Retrospective Feasibility Study. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs10803-018-3808-2
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and MetaAnalysis (abst–2018) https://link.springer.com/article/10.1007%2Fs40265-018-0992-5
Medical cannabis use in older patients: Update on medical knowledge. (abst – 2018)
https://www.maturitas.org/article/S0378-5122(18)30686-8/fulltext
Marijuana use in transplantation: A call for clarity. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30506888
Perceptions of the Comparative Safety of Different Forms of Marijuana Use Among the Adult US Population. (abst – 2018)
https://www.semanticscholar.org/paper/Perceptions-of-the-Comparative-Safety-of-Different-SodahmR.YooCamilleDollinger/64508455c7eb6f164bbf1b935e478cb347a784a9
2019 Cannabis and Cannabinoids (PDQ®) Patient Version. (full – 2019)
https://www.ncbi.nlm.nih.gov/books/NBK65875/
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336869/
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A
Review of the Evidence (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406915/
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for
Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a
Systematic Review. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369421/An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine.
(full – 2019) https://link.springer.com/article/10.1007%2Fs40122-019-0114-4
Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and
tolerability of cannabis galenical preparation (Bedrocan). (full – 2019)
https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396837/
Review of the many faces of synthetic cannabinoid toxicities. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/
Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. (full – 2019)
https://link.springer.com/article/10.1007%2Fs00213-019-05238-8
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514832/
The Australian drug harms ranking study. (full – 2019)
https://journals.sagepub.com/doi/full/10.1177/0269881119841569?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
Medical Marijuana: What Physicians Need to Know. (full – 2019)
https://www.psychiatrist.com/JCP/article/Pages/2019/v80/18ac12537.aspx
Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor
Performance and Anxiety in C57BL/6J Mice. (full – 2019)
https://www.frontiersin.org/articles/10.3389/fnbeh.2019.00094/full
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in
patients with severe chronic pain: analysis of 12-week open-label real-world data
provided by the German Pain e-Registry. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/
Safety and Efficacy of Medical Cannabis in Fibromyalgia. (Israel) (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/
Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged
Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration. (full – 2019)
https://www.mdpi.com/1420-3049/24/12/2256/htm
A systematic review of cannabidiol dosing in clinical populations. (full – 2019)
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14038
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. (full – 2019)
https://www.mdpi.com/2077-0383/8/7/989/htm
The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study. (full – 2019)
https://www.epilepsybehavior.com/article/S1525-5050(19)30305-1/fulltext
Should Oncologists Recommend Cannabis? (article – 2019) https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany)
(abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3
Women’s perspectives about cannabis use during pregnancy and the postpartum period: An integrative review. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0091743518303773?via%3Dihub
Epidiolex (Cannabidiol): A New Hope for Patients With Dravet or Lennox-Gastaut
Syndromes. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30616501
Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol. (abst – 2019)
https://pubs.acs.org/doi/10.1021/acschemneuro.8b00651
Cannabinoid toxicity in pediatrics. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30694824
Positive and Negative Effects of Cannabis and Cannabinoids on Health. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30703255
How effective and safe is medical cannabis as a treatment of mental disorders? A
systematic review. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30706168
A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. (abst – 2019)
https://link.springer.com/article/10.1007%2Fs11912-019-0757-7
Marijuana risk perceptions are associated with past-month marijuana use among Black first-year college students at a historically Black university. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30714497
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and
Potential. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer
Enrolled in Minnesota’s Medical Cannabis Program. (abst – 2019)
https://ascopubs.org/doi/abs/10.1200/JOP.18.00562?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jop
Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational
Study. (abst – 2019)
https://annals.org/aim/article-abstract/2729208/acute-illness-associated-cannabis-use-route-exposure-observationalstudy?doi=10.7326%2fM18-2809
Emergency Department Visits From Edible Versus Inhalable Cannabis. (abst – 2019)
https://annals.org/aim/article-abstract/2729210/emergency-department-visits-from-edible-versus-inhalablecannabis?doi=10.7326%2fM19-0542
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30910443
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics (abst–2019) https://www.sciencedirect.com/science/article/pii/S0163725819300750?via%3Dihub
Illegal cannabis use is common among Danes with multiple sclerosis. (abst – 2019)
https://www.msard-journal.com/article/S2211-0348(19)30212-3/fulltext
Cannabis-based medicines for chronic pain management: current and future prospects (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31356363
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31372958
Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study  (abst–2019) https://academic.oup.com/painmedicine/advance-article-abstract/doi/10.1093/pm/pnz153/5545189?redirectedFrom=fulltext
Medical marijuana use for pediatric oncology patients: single institution experience.
(Israel) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31424297


SAFETY-ADULTERANTS/CONTAMINANTS*+
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowers (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897766/
Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing (link to PDF–2015) https://www.jstage.jst.go.jp/article/jts/40/6/40_797/_article
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
False hashish without cannabis resin (abst–2015) http://www.ingentaconnect.com/search/article?option1=title&value1=false+hashish&pageSize=10&index=1
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/ Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089129/
Analysis of a commerical marijuana e-cigarette formulation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
Acute intoxication of four individuals following use of the synthetic cannabinoid MABCHMINACA (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27227269
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
High Time to Assess the Environmental Impacts of Cannabis Cultivation (full–2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Identification of a Widespread Palmitoylethanolamide Contamination in Standard  Laboratory Glassware (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510777/
Expert Panel on Understanding Cannabis: Medicine, Society, Government (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis  Concentrates (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Marijuana “bong” pseudomonas lung infection: a detrimental recreational experience  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756717/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and  pharmacological consequences (link to download–2017)  http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Endogenous synthesis of pyrethrins by cannabis (not all strains, just “Medihaze”, so far) (link to PDF–2017) http://www.biorxiv.org/content/early/2017/07/28/169417
Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28173984
What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis  sativa)? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28223891
Acute and residual effects in adolescent rats resulting from exposure to the novel  synthetic cannabinoids AB-PINACA and AB-FUBINACA (abst–2017)  http://journals.sagepub.com/doi/abs/10.1177/0269881116684336
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
The use of pesticides in Belgian illicit indoor cannabis plantations (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0379073817301871
Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment  (abst–2017) http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30438-3/fulltext
How four U.S. states are regulating recreational marijuana edibles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28343113
Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and
Oxidation Stability of European Commercially Available Preparations. (full – 2018)
http://www.mdpi.com/1420-3049/23/5/1230/htm
Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as
Cannabidiol — Utah, 2017–2018. (full – 2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6720a5.htm?s_cid=mm6720a5_w
Hepatitis A virus infection associated with cannabis use. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764743/
Butane hash oil and dabbing: insights into use, amateur production techniques, and
potential harm mitigation. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220730/
The Spice of Life…and Death: A Case Presentation and Review of Synthetic Marijuana
Use in Mississippi (full – pages 16-17 – 2018) https://issuu.com/jmsmamanagingeditor/docs/september_2016_jmsma_final_1.13.17
Cannabis Contaminants – sources, distribution, human toxicity and pharmacologic
effects. (full – 2018)
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13695
Infectious risks associated with medicinal Cannabis: Potential implications for
immunocompromised patients? (link to PDF–2018)
https://www.researchgate.net/publication/322990000_Infectious_risks_associated_with_medicinal_Cannabis_Potential_implications_for_immunocompromised_patients
Healthy and Concentrated Cannabis Plants: How to Use Acronyms to Optimize
Production (link to download – 2018)
https://www.ingentaconnect.com/content/aoac/jaoac/pre-prints/content-jaoac_180205;jsessionid=18xjnorbe71aw.x-ic-live-02#
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29370578
Cryptococcal meningitis in a daily cannabis smoker without evidence of
immunodeficiency. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29374632Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29438634
How Close to the “Honeypot?” A Comparative Analysis of Cannabis Markets Under
Two Different Policies Toward Personal Cultivation. (abst – 2018)
http://journals.sagepub.com/doi/full/10.1177/1057567717744857
Multiresidue Method of Analysis of Pesticides in Medical Cannabis. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29843862
Implementation of a generic SFC-MS method for the quality control of potentially
counterfeited medicinal cannabis with synthetic cannabinoids. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S1570023218302034?via%3Dihub
Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30022308
Hemorrhagic Highs from Synthetic Cannabinoids — A New Epidemic. (abst – 2018)
https://www.nejm.org/doi/full/10.1056/NEJMe1810418
Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618305490
Lung injury from inhaling butane hash oil mimics pneumonia. (full – 2019)
https://www.sciencedirect.com/science/article/pii/S2213007118303769?via%3Dihub
Pulmonary mucormycosis associated with medical marijuana use. (full – 2019)
https://www.sciencedirect.com/science/article/pii/S221300711830282X?via%3Dihub
Review of the many faces of synthetic cannabinoid toxicities. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/
Into the Weeds: Regulating Pesticides in Cannabis. (full – 2019)
https://ehp.niehs.nih.gov/doi/full/10.1289/EHP5265?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Emerging Public Health Law and Policy Issues Concerning State Medical Cannabis
Programs. (full – 2019)
https://journals.sagepub.com/doi/full/10.1177/1073110519857331?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
High-potency cannabis and incident psychosis: correcting the causal assumption. (3)
(full – 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30178-6/fulltext
Cannabis Contaminants: Regulating Solvents, Microbes, and Metals in Legal Weed.
(full – 2019) https://ehp.niehs.nih.gov/doi/full/10.1289/EHP5785?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Standard Method Performance Requirements (SMPRs®) 2018.011: Identification and
Quantitation of Selected Pesticide Residues in Dried Cannabis Materials (link to download – 2019)  https://www.ingentaconnect.com/content/aoac/jaoac/2019/00000102/00000001/art00044%3bjsessionid=1qpnsdzibf193.x-ic-live-01#
Why medical cannabis is still out of patients’ reach-an essay by David Nutt. (U.K.)(click “psprings” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Why+medical+cannabis+is+still+out+of+patients%27+reachan+essay+by+David+Nutt.&btnG
Adverse outcome pathway of developmental neurotoxicity resulting from prenatal
exposures to cannabis contaminated with organophosphate pesticide residues (abst – 2019) https://www.sciencedirect.com/science/article/pii/S089062381730518X?via%3Dihub
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and
Potential. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
Cannabis resin in the region of Madrid: Adulteration and contamination (abst–2019)
https://www.sciencedirect.com/science/article/pii/S0379073819300751?via%3Dihub
A sensitive multiresidue method for the determination of pesticides in marijuana by
liquid chromatography–tandem mass spectrometry. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S002196731930737X?via%3Dihub
Potential occupational and respiratory hazards in a Minnesota cannabis cultivation and processing facility. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31332812
Automated image analysis with ImageJ of yeast colony forming units from cannabis
flowers. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31381981
Comprehensive Determination of Unregulated Pesticide Residues in Oregon Cannabis Flower by LC-MS/MS and GC-MS/MS. (abst – 2019)
https://pubs.acs.org/doi/10.1021/acs.jafc.9b01559


SALIVARY GLANDS/SALIVA
Saliva of obese patients – is it different? (download–2015)  http://www.phmd.pl/fulltxt.php?ICID=1176778
The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular  gland: The influence of different physical forms of diets on their expression in piglets  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29218862
Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28549258
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking (abst–2018)  http://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C7FO01772C#!divAbstract
Cannabinoids for Treatment of Dystonia in Huntington’s Disease. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29562549Biological underpinnings from psychosocial stress towards appetite and obesity during youth: research implications towards metagenomics, epigenomics and metabolomics (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31298176
Salivary endocannabinoids as mediators in the relationship between omega-6 and omega-3 fatty acid ratio intake from highly-processed foods and anthropometric markers of health in women. (abst – 2019)
https://www.tandfonline.com/doi/abs/10.1080/09637486.2019.1632274?journalCode=iijf20


SCHISTOSOMA INFECTION+
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824


SCHIZOPHRENIA/MENTAL DISORDERS*+
An Introduction to the Endogenous Cannabinoid System (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789136/
Impact of Cannabis Use on the Development of Psychotic Disorders (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Synthetic cannabis-induced mania (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369931/
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst–2015) http://ijnp.oxfordjournals.org/content/18/5/pyu041.long
Cannabis and psychopathology: The meandering journey of the last decade (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676097/
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640936/
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (full–2015) http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Further human evidence for striatal dopamine release induced by administration of Δ9- tetrahydrocannabinol (THC): selectivity to limbic striatum (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816196/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537180/
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337703/
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT)
affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences (link to download–2015)  http://journals.sagepub.com/doi/full/10.1177/0269881115609073
Cannabis conundrum : Evidence of harm? : Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview-2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like  effects (abst-2015) https://www.ncbi.nlm.nih.gov/pubmed/25586398
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25680767
A systematic review of the antipsychotic properties of cannabidiol in humans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25667194
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
Association of single nucleotide polymorphisms in catechol-O-methyltransferase and serine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801838
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst–2015) http://www.psyn-journal.com/article/S0925-4927(15)00112-2/fulltext
Catatonia and Cannabis Withdrawal: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247767
No additive effect of cannabis on cognition in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26235754
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370602
Endocannabinoids and Mental Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26475744
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis (abst–2015) http://www.psy-journal.com/article/S0165-1781%2815%2930166-9/abstract
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26663094
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia:  Possible involvement of the endocannabinoid system (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26706691
Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26350340
top
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers (full–2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (full–2016) https://peerj.com/articles/2081/
Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report (full-2016) http://www.turkpsikiyatri.com/en/default.aspx?modul=article&id=1020
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10095&path%5B%5D=31745
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (full–2016) http://www.hindawi.com/journals/crips/2016/7257489/
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158779
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial (full–2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0160949
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00303/full
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature (full–2016) https://www.hindawi.com/journals/crips/2016/3640549/
Assessing causality in associations between cannabis use and schizophrenia risk: a twosample Mendelian randomization study (full–2016) https://www.cambridge.org/core/journals/psychological-medicine/article/div-classtitleassessing-causalityin-associations-between-cannabis-use-and-schizophrenia-risk-a-two-sample-mendelian-randomizationstudydiv/122D651C3670683DAEDDA33997417105/core-reader
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854973/
Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients (full–2016) https://www.dovepress.com/clinical-characteristics-of-synthetic-cannabinoid-induced-psychosis-in-peerreviewed-fulltext-article-NDT
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30509-8
Salience attribution and its relationship to cannabis-induced psychotic symptoms (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122315/
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis  Use (full–2016) https://academic.oup.com/schizophreniabulletin/article-lookup/doi/10.1093/schbul/sbw030
The endocannabinoid system and NGF are involved in the mechanism of action of  resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric
disorders (full–2016) http://link.springer.com/article/10.1007/s00213-015-4188-3
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients (click “full text links” for download–2016) https://www.ncbi.nlm.nih.gov/pubmed/28492376
Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in  Schizophrenia (1st page–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223%2816%2932303-4/abstract
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in
Individuals with Schizophrenia or Schizoaffective Disorder (abst–2016)  http://link.springer.com/article/10.1007/s11126-016-9426-2/fulltext.html
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis (abst–2016) http://journals.sagepub.com/doi/full/10.1177/0269881116658990
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive  deficits in first-episode psychosis (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26783729
Violence and self-harm in severe mental illness: inpatient study of associations with  ethnicity, cannabis and alcohol (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27679634
Cannabis and Psychosis: a Critical Overview of the Relationship (abst–2016)  http://link.springer.com/article/10.1007/s11920-015-0657-y
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia (abst–2016) http://link.springer.com/article/10.1007/s12035-016-9697-5
A Case of Butane Hash Oil (Marijuana Wax)-Induced Psychosis (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26820171
Cannabinoids for the Treatment of Schizophrenia: An Overview (abst–2016)  http://www.eurekaselect.com/139245/article
COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for  psychosis: Exploring Gene x Environment interactions (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27052366
Cannabis-induced psychosis associated with high potency “wax dabs” (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26876313
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816000396
Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970364 Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26987678
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256
Acute Psychosis after Consumption of Synthetic Cannabinoids (abst in German & English–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-103425
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597 (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27149691
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415302943
Could cannabidiol be used as an alternative to antipsychotics? (abst–2016) http://www.journalofpsychiatricresearch.com/article/S0022-3956(16)30104-2/abstract
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily Lives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27270874
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia (abst 016) http://www.schres-journal.com/article/S0920-9964(16)30060-3/abstract
Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27379411
Does cannabidiol have a role in the treatment of schizophrenia? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27374322
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616301269
Cannabis and a lower BMI in psychosis: What is the role of AKT1? (abst–2016) http://www.schres-journal.com/article/S0920-9964(16)30364-4/abstract
Cannabinoids and Psychosis (3) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568729
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia (abst–2016) http://www.psy-journal.com/article/S0165-1781(16)30347-X/fulltext
Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Cannabinoids: Glutamatergic Transmission and Kynurenines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Drug Dependence and Toxicity of Law-Evading Drugs: Their Mechanisms Explored from Basic Research (abst in English–2016) https://www.ncbi.nlm.nih.gov/pubmed/27703102  (abst in Japanese) http://medicalfinder.jp/doi/abs/10.11477/mf.1416200568
Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27734750
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797288
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) http://www.eurekaselect.com/146891/article
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence (abst–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00422/full
The effects of cannabis use on salience attribution: a systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866486
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
The consequences of chronic cannabis smoking in vulnerable adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27986504
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice (full–2017) http://link.springer.com/article/10.1007%2Fs12640-017-9702-4
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508788/
Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514308/
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
New drugs in psychiatry: focus on new pharmacological targets (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373420/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and  Directions for Basic Research (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478733/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447368/
Schizophrenia and depression, two poles of endocannabinoid system deregulation (full–2017) https://www.nature.com/articles/s41398-017-0029-y
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698868/
Short communication: Genetic association between schizophrenia and cannabis use  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28086176
A preliminary study of endocannabinoid system regulation in psychosis: Distinct  alterations of CNR1 promoter DNA methylation in patients with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28108228
Cannabis use, COMT, BDNF and age at first-episode psychosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28142064
Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric  Emergency Setting (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/10826084.2016.1263663?journalCode=isum20
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system:  Implications for novel schizophrenia treatments (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0149763416307102
Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28190094
Associations between substance use disorders and suicide or suicide attempts in people  with mental illness: A Danish nationwide, prospective, register-based study of patients  diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality  disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein  Predicts Cannabinoid-Antipsychotic Drug Interactions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28272498
Improved Social Interaction, Recognition and Working Memory with Cannabidiol  Treatment in a Prenatal Infection (poly I:C) Rat Model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28230072
Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28242263
Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent  schizophrenia patients versus non-psychiatric controls (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28285022
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic  Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia:  Evidence for defective immunomodulatory mechanisms (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0022395616307373
Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor  antagonist compounds co-administration in female rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28377074
The impact of current cannabis use on general cognitive function in people with  psychotic illness (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28381332
Cannabinoids as hippocampal network administrators (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301405?via%3Dihub
Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psychotic onset  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28412921
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28441106
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent  Patients with Schizophrenia versus Non-Psychiatric Controls (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28443616
Characteristics of socially withdrawn youth in France: A retrospective study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28446040
Synthetic cannabinoid use in an acute psychiatric inpatient unit (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28503792
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis (abst–2017) http://www.psy-journal.com/article/S0165-1781(17)30055-0/fulltext
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Voluntary exercise improves cognitive deficits in female dominant-negative DISC1  transgenic mouse model of neuropsychiatric disorders (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15622975.2017.1323118?journalCode=iwbp20
The relationship between cannabis use and cortisol levels in youth at ultra high-risk for  psychosis (abst–2017) http://www.psyneuen-journal.com/article/S0306-4530(17)30113-0/fulltext
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in  cannabinoid receptor levels that is prevented by high fat diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28619471
The association of cannabis use on inpatient psychiatric hospital outcomes (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28613973
Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to  phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice (abst–2017) http://www.sciencedirect.com/science/article/pii/S0091305717301211
At the intersection of neurology and psychiatry : the impact of the differential diagnosis  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653514
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat  model of schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28704273
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and  Related Conditions-III: Gender-specific profiles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28755613
Synthetic Cannabis Analogues and Suicidal Behavior: Case Report (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796120
Understanding marijuana’s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28823723
Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study (abst–2017) https://www.karger.com/Article/Abstract/479554
Is there a role for cannabidiol in psychiatry? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28112021
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4766-7
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids
imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Motivational changes of cannabis use prior to and during the course of schizophrenia  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28004866
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived Neurons (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29230395
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter  Randomized Controlled Trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29241357
Cannabis induced psychosis and subsequent psychiatric disorders (abst–2017)  http://www.asianjournalofpsychiatry.com/article/S1876-2018(17)30388-X/fulltext
The effect of interactions between genetics and cannabis use on neurocognition. A  review (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0278584617304785?via%3Dihub
Perspectives of cannabis use in the life experience of men with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29218823
The reasons for use of cannabinoids and stimulants in patients with schizophrenia.
(links to full in English & Polish – 2018) http://psychiatriapolska.pl/261_273_S

From “Azalla” to Anandamide: Distilling the Therapeutic Potential of Cannabinoids (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752109/
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and  bipolar disorder patients with cannabis use (full–2018)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)32024-2/fulltext
Prospective recovery of cannabis use in a psychotic population: A qualitative analysis (full – 2018) https://www.sciencedirect.com/science/article/pii/S2352853216300244?via%3Dihub
Dispensary cannabidiol marijuana and first-episode mania. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915243/
Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fgene.2018.00199/full
Therapeutic potential of medicinal marijuana: an educational primer for health care
professionals. (full – 2018)
https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-articleDHPS
The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00011/full
Substance Use and Psychological Disorders Among Art and Non-art University Students: an Empirical Self-Report Survey. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814514/
Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with
Schizophrenia: An Ecological Cross-Sectional Study. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037576/
Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. (full – 2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908414/
Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007529/
The Endocannabinoid System, Aggression, and the Violence of Synthetic Cannabinoid Use, Borderline Personality Disorder, Antisocial Personality Disorder, and Other Psychiatric Disorders. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fnbeh.2018.00041/full
The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. (full – 2018)
https://bsd.biomedcentral.com/articles/10.1186/s13293-018-0182-x
Evidence for the use of “medical marijuana” in psychiatric and neurologic disorders.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007658/
Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on
mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969305/
Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00281/full
Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis.
Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00294/full
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to
Acute Psychiatric Settings: Clinical Presentation and Management Issues. (full – 2018)
http://www.mdpi.com/2076-3425/8/7/133/htm
The Role of Cannabis within an Emerging Perspective on Schizophrenia. (full – 2018)
http://www.mdpi.com/2305-6320/5/3/86/htm
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00901/full
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with
schizophrenia. (full – 2018)
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0253-7
Lipidome alterations in human prefrontal cortex during development, aging, and
cognitive disorders. (full – 2018)
https://www.nature.com/articles/s41380-018-0200-8
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders.
(full – 2018) https://www.mdpi.com/2305-6320/5/4/107/htm
Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons. (full – 2018)
https://www.nature.com/articles/s41380-018-0243-x
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full
The impact of schizophrenia and intelligence on the relationship between age and brain volume. (full – 2018)  https://www.sciencedirect.com/science/article/pii/S2215001318300167?via%3Dihub
A successful microsurgical approach to treating penile amputation following genital self mutilation. (warning – graphic photos) (full – 2018)
https://academic.oup.com/jscr/article/2018/10/rjy271/5126893
Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine
neuron activity in a rodent model of schizophrenia susceptibility. (full – 2018)
https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy003/4796858
Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200442/
Mental Health Issues and Substance Use in the United States: Pulling the Power Levers (full – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30406713
Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol
Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058192/
Important Questions About the Impact of Medical Marijuana on People With Serious
Mental Illness. (full – 2018)
https://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.201800210?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset
Psychosis (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768049/
Sex differences in the cardiometabolic health of cannabis users with a psychotic illness (full–2018) https://www.sciencedirect.com/science/article/pii/S0376871618305787?via%3Dihub
Adult cellular neuroadaptations induced by adolescent THC exposure in female rats are rescued by enhancing anandamide signaling. (full – 2018)
https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy057/5047132
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex. (link to PDF – 2018) http://jpn.ca/43-2-87/
Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like
experiences in the offspring. (link to PDF – 2018)
https://www.researchgate.net/publication/326224957_Maternal_and_paternal_cannabis_use_during_pregnancy_and_the_risk_of_psychotic-like_experiences_in_the_offspring
Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: a cannabis discontinuation hypothesis (click “semanticscholar” for download – 2018) https://scholar.google.com/scholar?q=Psychoticlike+experiences+with+cannabis+use+predict+cannabis+cessation+and+desire+to+quit:+a+cannabis+discontinuation+hypothesis.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ9-tetrahydrocannabinol (D9-THC) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Reduced+type+III+neuregulin+1+expression+does+not+modulate+the+behavioural+sensitivity+of+mice+to+acute+%CE%94+9+-tetrahydrocannabinol+%28D+9+-THC%29&btnG=
Cannabinoids: just like any other medication? (article – 2018)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31611-8/fulltext
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0165178117311101
Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids. (abst – 2018)  https://www.ncbi.nlm.nih.gov/pubmed/29376979
Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients
experiencing first episode psychosis: Data from the national RAISE-ETP study (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29356438
Cannabinoids and glial cells: possible mechanism to understand schizophrenia.
(abst – 2018) https://www.semanticscholar.org/paper/Cannabinoids-and-glial-cells%3A-possible-mechanism-to-Almeida-Martins-deSouza/def584a15611061b5dfb80190421e150e7a3b491
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine,
serotonin, and glutamate systems. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29385930
Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818300510
Changes in dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618300681
Increased hippocampal engagement during learning as a marker of sensitivity to
psychotomimetic effects of δ-9-THC. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29502548
Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in
Schizophrenia Patients. (abst – 2018)
https://www.thieme-connect.com/DOI/DOI?10.1055/a-0573-9866
Effects of cannabis use on body mass, fasting glucose and lipids during the first
12 months of treatment in schizophrenia spectrum disorders. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29519756
Familial Abnormalities of Endocannabinoid Signaling in Schizophrenia. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29521179
Associations between adolescent cannabis use and brain structure in psychosis.
(abst – 2018) https://www.psyn-journal.com/article/S0925-4927(17)30314-1/fulltext
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29705007
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults
A Systematic Review and Meta-analysis. (abst – 2018)
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2678214?redirect=true
The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29743139
Is cannabis a risk factor for suicide attempts in men and women with psychotic illness? (abst – 2018) https://link.springer.com/article/10.1007%2Fs00213-018-4924-6
Childhood trauma- and cannabis-associated microstructural white matter changes in
patients with psychotic disorder: a longitudinal family-based diffusion imaging study (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29807550
Risk of criminal justice system involvement among people with co-occurring severe
mental illness and substance use disorder. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29852999
Attention deficit hyperactivity disorder and arrest history: Differential association of
clinical characteristics by sex. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29853005
Age of onset of Cannabis use and cognitive function in first-episode non-affective
psychosis patients: Outcome at three-year follow-up. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29861266
Cannabidiol effects on prepulse inhibition in nonhuman primates. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29794254
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters frontostriatal resting-state connectivity. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0924977X18301135
Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29974660
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia:
Implications for Pharmacological Intervention. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30022465
Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. (abst – 2018)  https://www.sciencedirect.com/science/article/pii/S0376871618303399
Age moderates the association between frequent cannabis use and negative schizotypy over time. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318304866
The endocannabinoid system in mental disorders: Evidence from human brain studies (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218302776
Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30070429
Trajectories of alcohol and marijuana use among primary versus secondary psychopathy variants within an adjudicated adolescent male sample. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30080061
The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0278584618300988?via%3Dihub
Impact of substance use disorder on gray matter volume in schizophrenia. (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0925492718300040?via%3Dihub
Psychosis and synthetic cannabinoids. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0165178117314312?via%3Dihub
Differences in demographic and clinical characteristics between cannabis users and nondrug users: A retrospective study of patients at first hospitalization due to psychotic symptoms. (abst – 2018)  https://www.sciencedirect.com/science/article/pii/S0165178118304062?via%3Dihub
Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015. (abst – 2018)
http://journals.sagepub.com/doi/abs/10.1177/0020764018795213?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Affect and cannabis use in daily life: a review and recommendations for future research (abst – 2018) https://www.sciencedirect.com/science/article/pii/S037687161830423X
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric
traits, and a causal influence of schizophrenia. (abst – 2018)
https://www.repository.cam.ac.uk/handle/1810/283624
Endocannabinoid signaling in psychiatric disorders: a review of positron emission
tomography studies. (abst – 2018) https://www.nature.com/articles/s41401-018-0081-z
Inhibition of return (IOR) in patients with schizophrenia and cannabis use (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0278584618305037?via%3Dihub
Genetic Predisposition vs Individual-Specific Processes in the Association Between
Psychotic-like Experiences and Cannabis Use. (abst – 2018)
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2707243
The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety
among Youth under 25 Years. (abst – 2018)
http://journals.sagepub.com/doi/abs/10.1177/0706743718809339?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cpab
Spicing it up – synthetic cannabinoid receptor agonists and psychosis – a systematic
review. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0924977X18308393?via%3Dihub
Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal
cortical executive function and regulation of affective behaviors. (abst – 2018)
https://www.nature.com/articles/s41386-018-0282-7
Cannabidiol in Anxiety and Sleep: A Large Case Series. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336340/
Review of the many faces of synthetic cannabinoid toxicities. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-
Tetrahydrocannabinol Administration in Humans. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523579/
High-potency cannabis and incident psychosis: correcting the causal assumption. (1)
(full – 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30130-0/fulltext
High-potency cannabis and incident psychosis: correcting the causal assumption. (2)
(full – 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30175-0/fulltext
Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?
(full – 2019) https://link.springer.com/article/10.1007%2Fs11920-019-1044-x
Synthetic Cannabinoids-“Spice” Can Induce a Psychosis: A Brief Review. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450675/
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits
Most? A Systematic Review. (full – 2019)
https://www.mdpi.com/2077-0383/8/7/1058/htm
Psychotic-like experiences and cannabis use in adolescents from the general population (link to PDFs in English & Spanish – 2019) http://adicciones.es/index.php/adicciones/article/view/1149
Synthetic cannabinoid use disorder: an update for general psychiatrists. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30663326
Effect of cannabis on weight and metabolism in first-episode non-affective psychosis:
Results from a three-year longitudinal study. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30702972
How effective and safe is medical cannabis as a treatment of mental disorders? A
systematic review. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30706168
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and
Potential. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
Cannabis use and violence in patients with severe mental illnesses: A meta-analytical investigation. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0165178118323862?via%3Dihub
What are the psychological effects of using synthetic cannabinoids? A systematic review (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30789300
Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0278584618307206?via%3Dihub
Cannabidiol attenuates aggressive behavior induced by social isolation in mice:
Involvement of 5-HT1A and CB1 receptors. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0278584618308340?via%3Dihub
The association between cannabis use and psychiatric comorbidity in people with
personality disorders: A population-based longitudinal study. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0165178119308662?via%3DihubMeasuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic
Review and Meta-analysis. (abst – 2019)
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2735110
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0278584619301393?via%3Dihub
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0889159119302806?via%3Dihub
Age of onset of substance use in patients with dual diagnosis and its association with
clinical characteristics, risk behaviors, course, and outcome: A retrospective study.
https://www.ncbi.nlm.nih.gov/pubmed/31391639
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia. (abst – 2019)
https://journals.sagepub.com/doi/abs/10.1177/0269881119857205?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jopa
Association of CNR1 genotypes with changes in neurocognitive performance after
eighteen-month treatment in patients with first-episode psychosis. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31398679
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling
markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S027858461930106X?via%3Dihub
Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice. (abst – 2019)
https://link.springer.com/article/10.1007%2Fs12035-019-1596-0
Cannabidiol (CBD) use in psychiatric disorders: A systematic. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0161813X19300774?via%3Dihub
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31422779
Psychiatrists cancel cannabis debate after no one would argue for criminalising users (1st paragraphs – 2019) https://www.bmj.com/content/364/bmj.l417.long


SCHWANNOMATOSIS
Including cannabinoids in the treatment of painful schwannomatosis (full–2018)
https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.1011


SCIATICIC NERVE INJURY
Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818304830
Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29528965
Supplementation of Cannabis sativa L. leaf powder accelerates functional recovery and ameliorates haemoglobin level following an induced injury to sciatic nerve in mouse model. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31103973


SCLERODERMA/SYSTEMIC SCLEROSIS+
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/
Cannabinoids, inflammation, and fibrosis. (full – 2016)
https://www.fasebj.org/doi/full/10.1096/fj.201600646R
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis? (link to PDF–2016) http://www.ima.org.il/imaj/ViewArticle.aspx?aId=3850
Cannabinoids and autoimmune diseases: A systematic review. (abst – 2016)
http://www.ncbi.nlm.nih.gov/pubmed/26876387
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst – 2016)
https://www.ncbi.nlm.nih.gov/pubmed/27859024
Ajulemic acid: potential treatment for chronic inflammation. (full – 2018)
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.394
Cannabinoids in dermatology: a scoping review. (full – 2018)
https://escholarship.org/uc/item/7pn8c0sb
The Therapeutic Potential of Cannabinoids in Dermatology. (full – 2018)
http://www.skintherapyletter.com/dermatology/cannabinoids-potential/Cannabinoids for the treatment of rheumatic diseases – where do we stand? (abst – 2018) https://www.nature.com/articles/s41584-018-0025-5
VCE-004.3, A CANNABIDIOL AMINOQUINONE DERIVATIVE, PREVENTS
BLEOMYCIN-INDUCED SKIN FIBROSIS AND INFLAMMATION TROUGH
PPARγ- AND CB2 -DEPENDENT PATHWAYS. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30033591
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates
bleomycin-induced skin and lung fibrosis. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0006295218303174
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0006295218303484
Nabilone administration in refractory chronic diarrhea: a case series. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid”
System (full–2019) https://www.mdpi.com/1420-3049/24/5/918/htm
Cannabis sativa as a Potential Treatment for Systemic Sclerosis. (link to PDF – 2019)
https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2019&month=03&page=217
Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for
systemic sclerosis. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0006295219300772?via%3Dihub

top


SEBACEOUS GLANDS+
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26142529
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27094344
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext
Recent advances in the endocrinology of the sebaceous gland. (full – 2018)
https://www.tandfonline.com/doi/full/10.1080/19381980.2017.1361576The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnesinduced inflammation and lipogenesis in sebocytes. (full – 2018)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202933
Endocannabinoid tone regulates human sebocyte biology. (link to PDF – 2018)
https://www.researchgate.net/publication/306420640_The_endocannabinoid_tone_regulates_human_sebocyte_biology
Effects of atopic dermatitis and gender on sebum lipid mediator and fatty acid profiles (abst – 2018) https://www.plefa.com/article/S0952-3278(17)30289-2/fulltext
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid”
System (full–2019) https://www.mdpi.com/1420-3049/24/5/918/htm


SEBORRHEA
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext


SEPTIC SHOCK/SEPSIS*+
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/100/6/F541
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376457/
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26925810
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator  constitutively secreted by adrenals and in liver upon tissue damage (full–2017)  https://www.nature.com/articles/s41598-017-09808-8
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via  Nonhematopoietic TRPV1 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544930/
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic  Shock (full–2017) http://www.mdpi.com/2218-1989/7/4/55/htm
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions,  Possibilities, and Challenges (full-2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Cannabinoids in the Cardiovascular System (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300431?via%3Dihub
Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of  Endotoxemia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28852269
An endocannabinoid uptake inhibitor from black pepper exerts pronounced antiinflammatory effects in mice (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human  sepsis? (full–2018) http://www.medical-hypotheses.com/article/S0306-9877(17)30861-7/fulltext


SEXUAL ABUSE
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of
Posttraumatic Stress Disorder: A Case Report (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent  Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/

Demographic and clinical characteristics of treatment seeking women with full and  subthreshold PTSD and concurrent cannabis and cocaine use disorders (full – 2017)
https://europepmc.org/articles/pmc5575989Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28826950
Influence of the type of childhood violence on cannabis abuse and dependence among adolescents: a systematic review and meta-analysis (abst in English, link to abst in Spanish – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30627731
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29310741
Regular past year cannabis use in women veterans and associations with sexual trauma (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S030646031830282X
Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30338584


SEXUAL MINORITIES
Where you live matters: Structural correlates of HIV risk behavior among young men who have sex with men in Metro Detroit (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248557/ (abst in English and Spanish – 2015) https://link.springer.com/article/10.1007%2Fs10461-015-1180-1
Gender minority social stress in adolescence: disparities in adolescent bullying and
substance use by gender identity. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201643/
Structural Stigma and Sexual Orientation Disparities in Adolescent Drug Use (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395540/
Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS. (full – 2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447557/
Sexual orientation disparities in psychiatric and drug use disorders among a nationally representative sample of women with alcohol use disorders. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417371/
An alcohol, tobacco, and other drug use comparison of lesbian, bisexual, and
heterosexual undergraduate women. (abst – 2015)
https://www.tandfonline.com/doi/abs/10.3109/10826084.2014.980954?journalCode=isum20
Adolescent Sexual Minority Girls Are at Elevated Risk for Use of Multiple Substances.
(full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888964/
Substance use among adolescent sexual minority athletes: A secondary analysis of the youth risk behavior survey. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835837/Identifying HIV care enrollees at-risk for cannabis use disorder. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573588/
The curvilinear effects of sexual orientation on young adult substance use  (download–2016) https://static1.squarespace.com/static/55efa8b5e4b0c21dd4f4d8ee/t/58913cb4579fb38e735d8123/1485913274081/Parnes+et+al.pdf
Substance Use Among Sexual Minority Collegiate Athletes: A National Study (abst–2016) https://www.sciencedirect.com/science/article/pii/S2352853216300165
Sexual orientation, minority stress, social norms, and substance use among racially
diverse adolescents. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575887/
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncannabis) Drug Use Among a Large Sample of Transgender People in the United States (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516932/
Daily-level associations between PTSD and cannabis use among young sexual minority women (link to PDF–2017)  https://www.researchgate.net/publication/317424016_Dailylevel_associations_between_PTSD_and_cannabis_use_among_young_sexual_minority_women
Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28826950
Sexual orientation disparities in the co-occurrence of substance use and psychological distress: a national population-based study (2008-2015). (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862943/
A three-city comparison of drug use and drug use before sex among young men who
have sex with men in the United States. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205241/
Violence Victimization, Substance Use, and Suicide Risk Among Sexual Minority High
School Students – United States, 2015-2017. (full – 2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6743a4.htm?s_cid=mm6743a4_w
Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083846
Prevalence of Substance Use among Lesbian, Gay, Bisexual, and Transgender Youth in Military Families: Findings from the California Healthy Kids Survey. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29303404
Prevalence and Correlates of Substance Use in Homeless Youth and Young Adults.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29505458
A mediated multigroup model examining marijuana use consequences by sexual
orientation in us college students. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318306646Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1
Infection. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29982500
Substance Use Among Lesbian, Gay, Bisexual, and Questioning Adolescents in the
United States, 2015. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29995487
Effects of romantic involvement on substance use among young sexual and gender
minorities. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618304228
Associations Between Cannabis Use, Sexual Behavior, and STIs/HIV in a Cohort of
Young Men Who Have Sex with Men. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30278026
Exposure to community violence and substance use among Black men who have sex with men: examining the role of psychological distress and criminal justice involvement (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30280579
Regular past year cannabis use in women veterans and associations with sexual trauma (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S030646031830282X
Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30338584
Supporting Transgender and Gender Diverse Youth: Protection Against Emotional
Distress and Substance Use (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/30344037
Sexual minority women and Cannabis use: The serial impact of PTSD symptom severity and coping motives. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318307275?via%3Dihub
Effects of victimization on mental health and substance use trajectories in young sexual minority men. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30585567
Differences in Substance Use Disparities Across Age Groups in a National Cross Sectional Survey of Lesbian, Gay, and Bisexual Adults. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434594/
Sexual Minority Youth at Risk of Early and Persistent Alcohol, Tobacco, and Marijuana Use (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30604172
Substance Use and School Characteristics in Lesbian, Gay, Bisexual, and Heterosexual High School Students. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30637738
Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted
Infections/Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex
With Men. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30640212
Not getting high with a little help from your friends: Social versus drug network
correlates of marijuana use among YMSM. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318308244?via%3Dihub
A longitudinal analysis of cannabis use and mental health symptoms among gay,
bisexual, and other men who have sex with men in Vancouver, Canada. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0165032718319293?via%3Dihub
Does the association between substance use and sexual risk behaviors among high school students vary by sexual identity? (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318307627?via%3Dihub
Adverse childhood experiences and MSM marijuana use. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0376871619300572?via%3Dihub


SICKLE CELL DISEASE+
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients (full–2015)  http://www.bloodjournal.org/content/128/22/5913?sso-checked=true
Quantification of pain in sickle mice using facial expressions and body measurements (abst–2016) http://www.sciencedirect.com/science/article/pii/S1079979615300218
Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26956672
The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of
Hospitalization due to Vaso-Occlusive Crises (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627667/
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local  inhibition of anandamide hydrolysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28570479
Marijuana Use in Adults Living with Sickle Cell Disease. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044416/
Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study. (full – 2019)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2734070


SINUSITIS
Cannabis and crossed allergy with food (abst in English & French – 2017) http://www.em-consulte.com/article/1183746/alertePM
Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated
respiratory disease: a pilot study. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29897665
Impact of habitual marijuana and tobacco smoke on severity of chronic rhinosinusitis (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0196070919302881?via%3Dihub


SKIN
Lipid mediator profile in vernix caseosa reflects skin barrier development (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629127/
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays  skin graft rejection through activation of cannabinoid receptor 1 and induction of  myeloid-derived suppressor cells (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541500/
Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes  Remodeling of Extracellular Matrix and Wound Closure Activation (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539444/
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human  cheek skin sebum and erythema content (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26142529
Cannabinoid CB2 receptors are involved in the regulation of fibrogenesis during skin  wound repair in mice (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805070/
Differential effectiveness of selected non-psychotropic phytocannabinoids on human  sebocyte functions implicates their introduction in dry/seborrheic skin and acne  treatment (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27094344
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation,  fibrogenesis, and promotes re-epithelialization during skin wound healing (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27268717
Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898
Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems  interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and  hydrogen peroxide (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387039/
Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on  cutaneous ceramides, in a human skin organ culture model (full–2017)  http://www.sciencedirect.com/science/article/pii/S0005273617300986
The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin  Inflammation in Mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28214870
Lipidomics for translational skin research: a primer for the uninitiated. (full – 2018)
https://onlinelibrary.wiley.com/doi/full/10.1111/exd.13558
Skin Prick Test Reactivity to Common Aeroallergens among Allergic Rhinitis Patients.
(link to download – 2018) https://www.jcpsp.pk/archive/2018/Oct2018/10.pdf
Cannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-α: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitis (abst in English & links to 6 others – 2018) https://onlinelibrary.wiley.com/doi/full/10.1111/vde.12658
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. (abst – 2018)  https://www.sciencedirect.com/science/article/abs/pii/S0006295218303484
Fatty acids and related lipid mediators in the regulation of cutaneous inflammation  (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29330355
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid”
System. (full – 2019) https://www.mdpi.com/1420-3049/24/5/918/htm
Modulators of the endocannabinoid system influence skin barrier repair, epidermal
proliferation, differentiation and inflammation in a mouse model. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31350927


SLEEP APNEA+
Emerging Drugs for Common Conditions of Sleepiness: Obstructive Sleep Apnea and Narcolepsy (full–2015) http://www.tandfonline.com/doi/full/10.1517/14728214.2015.1115480
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea (full–2016) http://www.hindawi.com/journals/bmri/2016/9782031/
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats (full–2016) http://jnrbm.biomedcentral.com/articles/10.1186/s12952-016-0052-1
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Cannabis, Cannabinoids, and Sleep: a Review of the Literature (abst–2017)  http://link.springer.com/article/10.1007%2Fs11920-017-0775-9
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague Dawley Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28934522
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial:  Effects of Dronabinol in Obstructive Sleep Apnea (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29121334
Role of the endogenous cannabinoid receptor 1 in brain injury induced by chronic  intermittent hypoxia in rats (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29264962


SLEEP DISORDERS/PARASOMNIAS
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a
comprehensive review. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of
Posttraumatic Stress Disorder: A Case Report. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/
Treatment of REM Sleep Behavior Disorder. (abst – 2017)
https://link.springer.com/article/10.1007%2Fs11940-016-0433-2
Characteristics of socially withdrawn youth in France: A retrospective study.
(abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28446040
Exploring Interventions for Sleep Disorders in Adolescent Cannabis Users.
(full – 2018) http://www.mdpi.com/2076-3271/6/1/11/htm
Therapeutic Symptomatic Strategies in the Parasomnias. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs11940-018-0508-3
Management of Post-Traumatic Nightmares: a Review of Pharmacologic and
Nonpharmacologic Treatments Since 2013. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs11920-018-0971-2
Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and
tolerability of cannabis galenical preparation (Bedrocan). (full – 2019)
https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care
Symptoms. (full – 2019)
https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
The use of cannabinoids for sleep: A critical review on clinical trials. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31120284
The Endocannabinoid System May Modulate Sleep Disorders In Aging. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31368874


SLEEP MODULATION*+
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (full–2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
top

Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338251
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by  Parkinson’s Disease Patients in Colorado (full–2015)  http://www.hindawi.com/journals/ecam/2015/874849/
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the  modulation of distinct panic-like responses (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25601395
The effects of chronic marijuana use on circadian entrainment (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25801606
Cannabis withdrawal and sleep: A systematic review of human studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25893849
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Rhythmic control of endocannabinoids in the rat pineal gland (abst–2015) http://informahealthcare.com/doi/abs/10.3109/07420528.2015.1041596
Endocannabinoid Signaling Regulates Sleep Stability (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152473
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
The impact of drugs for multiple sclerosis on sleep (full–2016) http://journals.sagepub.com/doi/full/10.1177/1352458516664034
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a
comprehensive review (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep  quality in emerging adults: a pilot study (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289074/
Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and  Maintenance of Wakefulness Test (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155193/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on  Executive Function (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016) https://link.springer.com/article/10.1007%2Fs00429-016-1214-0
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27160412
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27746343
Endocannabinoids and sleep (abst-2016) http://www.sciencedirect.com/science/article/pii/S0149763416302640
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of  THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016)  https://www.karger.com/Article/Abstract/445943
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Recent legalization of cannabis use: effects on sleep, health, and workplace safety (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656354/
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
The endocannabinoid system modulating levels of consciousness, emotions and likely  dream contents (abst–2017) http://www.eurekaselect.com/150392/article
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A  literature review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28245077
Prevalence of teenage sleeping disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28242150
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Cannabis, Cannabinoids, and Sleep: a Review of the Literature (abst–2017)  http://link.springer.com/article/10.1007%2Fs11920-017-0775-9
Anandamide and 2-AG Are Endogenously Present within the Laterodorsal Tegmental  Nucleus: Functional Implications for a role of eCBs in arousal (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28404451
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
Effects of sleep on substance use in adolescents: a longitudinal perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547821
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
Daily associations between cannabis motives and consumption in emerging adults (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30278-8/fulltext
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night
reorganization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28669028
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Drowsiness and uncommon fever in a child after cannabis ingestion (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28751294
Sleep continuity, architecture and quality among treatment-seeking cannabis users: An in-home, unattended polysomnographic study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28782982
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague Dawley Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28934522
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28537982
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923
Peripheral Endocannabinoids Associated with Energy Expenditure in Native Americans of Southwestern Heritage (abst–2017)  https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/jc.2017-02257/4780813?redirectedFrom=fulltext
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Exploring Interventions for Sleep Disorders in Adolescent Cannabis Users (full – 2018) http://www.mdpi.com/2076-3271/6/1/11/htm
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A
Randomized, Double-Blind, Placebo-Controlled, Crossover Study. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00315/full
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under
Naturalistic Conditions (full–2018) http://www.mdpi.com/2305-6320/5/3/75/htm
A Cross-Sectional Study of Cannabidiol Users. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/
Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16).
(full – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30092752
The Consumption of Cannabis by Fibromyalgia Patients in Israel. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/
Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol
Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058192/
Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain. (full – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618307786?via%3Dihub
Cannabis for peripheral neuropathy: The good, the bad, and the unknown (full–2018)
https://www.mdedge.com/ccjm/article/189782/drug-therapy/cannabis-peripheral-neuropathy-good-bad-and-unknown
Prospective analysis of safety and efficacy of medical cannabis in large unselected
population of patients with cancer (Israel) (click “researchgate” for download–2018)
https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Practical considerations in medical cannabis administration and dosing (link to PDF–2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
Medical Cannabis for Older Patients (link to PDF–2018)  https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients
Made from concentrate? A national web survey assessing dab use in the United States (link to PDF – 2018)  https://www.researchgate.net/publication/325991896_Made_from_concentrate_A_national_web_survey_assessing_dab_use_in_the_
United_States
The therapeutic effects of Cannabis and cannabinoids: An update from the National
Academies of Sciences, Engineering and Medicine report. (abst – 2018)
http://www.ejinme.com/article/S0953-6205(18)30003-7/fulltext
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29524396
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs00520-018-4154-9
Cannabis for Chronic Pain: Challenges and Considerations. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29637590
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29659126
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/0883073818773028?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats. (abst – 2018) https://www.semanticscholar.org/paper/Systemic-Injections-of-Cannabidiol-Enhance-Levels-Murillo-Rodr%C3%ADguezArankowsky-Sandoval/4cdc20e53bdba1a6072248c6333bf292bc3c486a
Medicinal versus Recreational Cannabis Use among Returning Veterans. (abst – 2018)
http://psycnet.apa.org/doiLanding?doi=10.1037%2Ftps0000133
What do we know about the pharmacotheraputic management of insomnia in cannabis withdrawal: A systematic review. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30113101
Insomnia and Regulation of Sleep-Wake Cycle With Drugs Among Adolescent Risky
Drinkers. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30176972
Differential relationships between cannabis consumption and sleep health as a function of HIV status. (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618304988?via%3Dihub
Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30291748
Single center experience with medical cannabis in Gilles de la Tourette syndrome.
(abst – 2018) https://www.prd-journal.com/article/S1353-8020(18)30429-2/fulltext
Cannabidiol affects circadian clock core complex and its regulation in microglia cells (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30307084
Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure. (abst – 2018)
https://academic.oup.com/jcem/article/103/10/3757/5063487
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. (abst – 2018) https://www.msard-journal.com/article/S2211-0348(18)30515-7/fulltext
Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30540595
Cannabidiol in Anxiety and Sleep: A Large Case Series. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
∆9-Tetrahydrocannabinol, a major marijuana component, enhances the anesthetic effect of pentobarbital through the CB1 receptor. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314990/
Cannabidiol in Anxiety and Sleep: A Large Case Series. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care. (full – 2019)  https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0533?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care
Symptoms. (full – 2019)
https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Should Oncologists Recommend Cannabis? (article – 2019)
https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Acute effect of vaporized Cannabis on sleep and electrocortical activity. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0091305718304714?via%3Dihub
Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30572744
Triple comorbid trajectories of alcohol, cigarette, and marijuana use from adolescence to adulthood predict insomnia in adulthood. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318306385?via%3Dihub
Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30801394
Early adolescent drinking and cannabis use predicts later sleep-quality problems.
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30869923
Insomnia symptoms, cannabis protective behavioral strategies, and hazardous cannabis use among U.S. college students. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30907602
The use of cannabinoids for sleep: A critical review on clinical trials. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31120284
Illegal cannabis use is common among Danes with multiple sclerosis. (abst – 2019)
https://www.msard-journal.com/article/S2211-0348(19)30212-3/fulltext
Cannabis and alcohol use for sleep aid: A daily diary investigation. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31169378
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use
Dispensary. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31264536
Cannabis Expectancies for Sleep. (abst – 2019)  https://www.ncbi.nlm.nih.gov/pubmed/31319769
The Endocannabinoid System May Modulate Sleep Disorders In Aging. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31368874
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical
implications. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31207606
Opportunities for cannabis in supportive care in cancer. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31413731


SMALLPOX+
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015) http://www.hindawi.com/journals/mi/2015/349176/

top


SMELL/OLFACTORY SYSTEM/ODOR DETECTION+
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Detection of Illicit Drugs by Trained Honeybees (Apis mellifera) (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471073/ 

A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162535
A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148734
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26996621
Effects of analgesics on olfactory function and the perception of intranasal trigeminal stimuli (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27320501
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27606334
top
The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica essential oil inhalation in a mouse model of postoperative pain (full–2017)  http://www.sciencedirect.com/science/article/pii/S0378874117320172?via%3Dihub 

Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in  healthy non-addicted subjects (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28866743 
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to  Supercritical CO2 Concentrate (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28926863 
LEARNING-INDUCED MODULATION OF THE EFFECT OF ENDOCANNABINOIDS ON INHIBITORY SYNAPTIC TRANSMISSION (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167327
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to
Supercritical CO2 Concentrate (link to 1st page – 2017) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-119361
Neuromodulation of Synaptic Transmission in the Main Olfactory Bulb. (full – 2018)
https://www.mdpi.com/1660-4601/15/10/2194/htm
Consumer perceptions of strain differences in Cannabis aroma (link to download – 2018) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192247
The Terroir of Cannabis: Terpene Metabolomics as a Tool to Understand Cannabis sativa Selections (link to 1st page – 2019) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-0915-2550
CB1 Receptors in the Anterior Piriform Cortex Control Odor Preference Memory.
(abst–2019)
https://www.cell.com/current-biology/fulltext/S0960-9822(19)30768-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0960982219307687%3Fshowall%3Dtrue


SMOKED CANNABIS AS A MEDICATION*+
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) (full–2015) http://cid.oxfordjournals.org/content/61/1/40.long
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519555/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (full–2015) http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (full–2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801109/ 
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087 
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) (full–2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (full–2015) http://www.goldjournal.net/article/S0090-4295(14)01206-0/fulltext
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588

Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716(15)01646-4/abstract
top
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900250-1/abstract
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165

“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Neuropathic Pain Treatment: Still a Challenge (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935814/
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic  Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869907/ 
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889592
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045 

The use of medical-grade cannabis in patients non-responders to Nabiximols (1st page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population  (abst–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full 

Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies (abst in German & English) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y
Plant-Derived and Endogenous Cannabinoids in Epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26892745
Cannabinoids: Medical implications (abst–2016) http://www.tandfonline.com/doi/abs/10.3109/07853890.2016.1145794?journalCode=iann20C
Cannabis in Pain Treatment: Clinical & Research Considerations (abst–2016)  http://www.jpain.org/article/S1526-5900(16)00543-5/fulltext
Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
No significant effect of cannabis use on the count and percentage of circulating CD4 Tcells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27073179
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27267445
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883 Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst in German & English-2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723182
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017) https://www.ncbi.nlm.nih.gov/books/NBK65875/ 

Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176416
Cannabis and cognitive functioning in multiple sclerosis: The role of gender (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/
Is cannabis an effective treatment for joint pain? (link to PDF-2017)  http://www.clinexprheumatol.org/abstract.asp?a=12225
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A  literature review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28245077 

Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Cannabis and Cannabinoids for Chronic Pain. (abst – 2017)
https://link.springer.com/article/10.1007%2Fs11926-017-0693-1
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under
Naturalistic Conditions. (full – 2018)
http://www.mdpi.com/2305-6320/5/3/75/htm
The association of therapeutic versus recreational marijuana use and antiretroviral
adherence among adults living with HIV in Florida. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067624/
The Consumption of Cannabis by Fibromyalgia Patients in Israel. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/
FDA Grants Orphan Drug Designation to Cannabis Pellet. (article – 2018)
https://www.practicalpainmanagement.com/treatments/pharmacological/fda-grants-orphan-drug-designation-cannabis-pellet
Cannabis for the treatment of ulcerative colitis (summary in English & Spanish–2018) https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012954.pub2/full
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29463913
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (abst – 2018)  https://www.ncbi.nlm.nih.gov/pubmed/29524396
Pain interference and alcohol, nicotine, and cannabis use disorder in a national sample of substance users. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618301169
Should ophtalmologists recommend medical cannabis to patients with glaucoma?
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30020072
TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids. (abst – 2018)
https://www.prd-journal.com/article/S1353-8020(18)30427-9/fulltext
2019 Cannabis and Cannabinoids (PDQ®) Patient Version. (full – 2019)
https://www.ncbi.nlm.nih.gov/books/NBK65875/
The Association between Cannabis Product Characteristics and Symptom Relief (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389973/
A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of
Chronic Neuropathic Pain. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446169/
Safety and Efficacy of Medical Cannabis in Fibromyalgia. (Israel) (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
(full – 2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00339/full
Cannabis sativa as a Potential Treatment for Systemic Sclerosis. (link to PDF – 2019)
https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2019&month=03&page=217
Cannabis for medical purposes and its prescription. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02970-6
Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians  (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-0387-x
Long-term medical cannabis use and risk factors for diversion: report on physician’s
guidance and patients’ behaviour. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31190678


SOCIAL ADJUSTMENT/BEHAVIOR*+
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Stigma among California’s Medical Marijuana Patients (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341951/
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681836/
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety like behavior and sociability (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00235/full
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441859/
Young adult cannabis users report greater propensity for risk-taking only in non-monetary domains (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297698/ 
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (full–2015) http://www.sciencedirect.com/science/article/pii/S0149763415001244
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592162/
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491148/
Twitter Chatter about Marijuana (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306811/
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646225/
Cannabidiol as a Potential Treatment for Anxiety Disorders (full–2015) http://link.springer.com/article/10.1007/s13311-015-0387-1
Effects of amphetamine, morphine, and CP 55, 940 on Go/No-Go task performance in rhesus monkeys (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497858/
Maternal separation and early stress cause long-lasting effects on dopaminergic and  endocannabinergic systems and alters dendritic morphology in the nucleus accumbens  and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of  threat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801124/ 

Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement (full–2015) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/
Early onset of cannabis use: Does personality modify the relation with changes in  perceived parental involvement? (click “academia” for download–2015)  https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Early+onset+of+cannabis+use%3A+Does+personality+modify+the+relation+with+changes+in+perceived+parental+involvement%3F+++++++++++++++&btnG
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions  (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26527537

Dissecting the cannabinergic control of behavior: The where matters (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26260530
Role of CB2 receptors in social and aggressive behavior in male mice (abst–2015) http://link.springer.com/article/10.1007%2Fs00213-015-3939-5
From substance use to homelessness or vice versa? (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0277953615002786U
Use and effects of cannabinoids in military veterans with post-traumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26391492
top
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26706691
Who receives cannabis use offers: A general population study of adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26433564
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26747370
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26212076
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25785792
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social  behavior and emotionality at different developmental ages in rats (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25914159 

Subjective and behavioral effects of marijuana the morning after smoking (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/2315429
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914428/ 

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803149/
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110529/
Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147422/
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13645/full
Discriminability of personality profiles in isolated and Co-morbid marijuana and nicotine users (full–2016) http://www.psy-journal.com/article/S0165-1781(16)30273-6/fulltext
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/ 

Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013 (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957692/ 
Neural mechanisms of sensitivity to peer information in young adult cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955693/ 
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/ 
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904780/ 
The Effect of Medical Marijuana on Sickness Absence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27416978 
A Genetic Component to National Differences in Happiness (abst–2016) http://link.springer.com/article/10.1007/s10902-015-9712-y
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
From “herbal highs” to the “heroin of cannabis”: Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0955395916000347
Social defeat leads to changes in the endocannabinoid system; an overexpression of calreticulin and motor impairment in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300328
Cross-section and panel estimates of peer effects in early adolescent cannabis use: With a little help from my ‘friends once removed’ (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0277953616303021 

Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597 (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily Lives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27270874
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
The neurobiology of social play and its rewarding value in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816308660
Risky substance use and peer pressure in Swiss young men: Test of moderation effects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27632359
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30923-1/abstract
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27750184
The neurobiology of social play and its rewarding value in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445
A social network analysis of substance use among immigrant adolescents in six European cities (abst–2016) http://www.sciencedirect.com/science/article/pii/S027795361630538X
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst–2016) http://www.sciencedirect.com/science/article/pii/S089142221630230X
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass  index trajectory among Mexican American adolescents (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27228958
Using Attitudes, Age and Gender to Estimate an Adolescent’s Substance Use Risk (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417548/ 

Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for  Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/ 
Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in Mice (full–2017) http://www.mdpi.com/1422-0067/18/8/1635
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana (full–2017)  http://pediatrics.aappublications.org/content/139/4/e20162675.long 
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531370/ 
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models (full–2017) http://www.mdpi.com/1422-0067/18/9/1916/htm 
Endocannabinoid system in sexual motivational processes: is it a novel therapeutic horizon? (full–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816312385
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent  Behavioral Deficits That Can Be Improved by NeurosteroidBased Treatment (full2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
Effects of cannabis use and subclinical depression on the P3 eventrelated potential in an emotion processing task (full2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371467/
Chronic Adolescent Δ9Tetrahydrocannabinol Treatment of Male Mice Leads to LongTerm Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent  Cannabidiol (full2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/  Treatment seeking in cannabis dependence: The role of social cognition (full2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)31002-X/fulltext
Assessing the experience of using synthetic cannabinoids by means of interpretative  phenomenological analysis (full2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303230/
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist,  rimonabant, on emotional processing (download2017) thcint.com
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA (full–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881116684336?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse (abst–2017) http://www.sciencedirect.com/science/article/pii/S0277953617300011
Cannabis use and dating violence among college students: A call for research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28109121
Social factors in marijuana use for medical and recreational purposes (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
Alternate policing strategies: Cost-effectiveness of cautioning for cannabis offences (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28139329
Cannabinoids activate monoaminergic signaling to modulate key C. elegans behaviors (abst–2017) http://www.jneurosci.org/content/37/11/2859.long

URB597 reduces biochemical, behavioral and morphological alterations in two  neurotoxic models in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28157650 
Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor (abst–2017)  http://link.springer.com/article/10.1007%2Fs00213-017-4548-2 
The endocannabinoid system modulating levels of consciousness, emotions and likely dream contents (abst–2017) http://www.eurekaselect.com/150392/article
Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28237711 

Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28230072
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Substance Use in Undergraduate Students With Histories of Attention-Deficit / Hyperactivity Disorder (ADHD): The Role of Impulsivity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28406351 

Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via  changes in brain endocannabinoid system (abst–2017)  http://www.jlr.org/content/58/2/301.abstract 
Characteristics of socially withdrawn youth in France: A retrospective study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28446040 
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417300659
Nucleus Accumbens Functional Connectivity at Age 20 is Associated with Trajectory of  Adolescent Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547854
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Endocannabinoid Signaling in the Control of Social Behavior (abst–2017)  http://www.cell.com/trends/neurosciences/abstract/S0166-2236(17)30077-2
Blunted stress reactivity in chronic cannabis users (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4648-z
Recommendation to reconsider examining cannabis subtypes together due to opposing  effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30220-X/fulltext
Family Structure and Adolescent Substance Use: An International Perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605218
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning (abst–2017)  http://journals.sagepub.com/doi/abs/10.1177/1087054716685842?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Daily associations between cannabis motives and consumption in emerging adults Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28705601
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Adolescent peer networks and the moderating role of depressive symptoms on  developmental trajectories of cannabis use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28738220
Substance Use in Young Swiss Men: The Interplay of Perceived Social Support and  Dispositional Characteristics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28379109
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse  hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Social factors in marijuana use for medical and recreational purposes (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further  evidence for transporter-mediated endocannabinoid release (abst–2017)  https://www.sciencedirect.com/science/article/pii/S002839081730549X?via%3Dihub
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids
imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Motivational changes of cannabis use prior to and during the course of schizophrenia  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28004866
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction  Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29265107
Activation of the cannabinoid system in the nucleus accumbens affects effort-based  decision making (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0091305717301387?via%3Dihub
Four Mechanistic Models of Peer Influence on Adolescent Cannabis Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29104847
Inspired by Mary Jane? Mechanisms underlying enhanced creativity in cannabis users  (abst–2017)  https://www.sciencedirect.com/science/article/pii/S1053810017303744?via%3Dihub
The Intergenerational Transmission of Cannabis Use: Associations Between Parental  History of Cannabis Use and Cannabis Use Disorder, Low Positive Parenting, and  Offspring Cannabis Use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29189023
The reasons for use of cannabinoids and stimulants in patients with schizophrenia.
(links to full in English & Polish – 2018) http://psychiatriapolska.pl/261_273_S
The selective reversible FAAH inhibitor, SSR411298, restores the development of
maladaptive behaviors to acute and chronic stress in rodents. (full – 2018)
https://www.nature.com/articles/s41598-018-20895-z
Nineteen and Up study (19Up): understanding pathways to mental health disorders in young Australian twins. (full – 2018)
http://bmjopen.bmj.com/content/8/3/e018959.long
CB1R-Mediated Activation of Caspase-3 Causes Epigenetic and Neurobehavioral
Abnormalities in Postnatal Ethanol-Exposed Mice. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00045/full
Studying Cannabis Use Behaviors With Facebook and Web Surveys: Methods and
Insights. (full – 2018) http://publichealth.jmir.org/2018/2/e48/
Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fgene.2018.00199/full
Impulsivity traits and addiction-related behaviors in youth. (full – 2018)
https://akademiai.com/doi/full/10.1556/2006.7.2018.22
Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with
Schizophrenia: An Ecological Cross-Sectional Study. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037576/
Age of onset of cannabis use and decision making under uncertainty. (full – 2018)
https://peerj.com/articles/5201/
Religious Involvement and Marijuana Use for Medical and Recreational Purposes.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989257/
Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis.
Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence (full–2018)  https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00294/full
Long-Term Stress and Concomitant Marijuana Smoke Exposure Affect Physiology,
Behavior and Adult Hippocampal Neurogenesis. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00786/full
Dissociable psychosocial profiles of adolescent substance users. (full – 2018)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202498
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00901/full
Peripubertal stress increases play fighting at adolescence and modulates nucleus
accumbens CB1 receptor expression and mitochondrial function in the amygdala.
(full – 2018) https://www.nature.com/articles/s41398-018-0215-6
Effects of an early life experience on rat brain cannabinoid receptors in adolescence and adulthood. (full – 2018)
https://www.sciencedirect.com/science/article/pii/S2451830117300511?via%3Dihub
Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines. (full – 2018)
https://www.ncbi.nlm.nih.gov/books/NBK526373/
Exploring the association of legalisation status of cannabis with problematic cannabis use and impulsivity in the USA. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152614/
Sex Difference: What does cannabis do to the brain before birth? (full – 2018)
https://elifesciences.org/articles/41229
Violence Victimization, Substance Use, and Suicide Risk Among Sexual Minority High
School Students – United States, 2015-2017. (full – 2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6743a4.htm?s_cid=mm6743a4_wA cannabinoid receptor type 1 (CB1R) agonist enhance the developmental neurotoxicity of acetaminophen (paracetamol). (full – 2018)
https://academic.oup.com/toxsci/article/166/1/203/5079325
Sex-dependent effects of in utero cannabinoid exposure on cortical function.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162091/
Cannabis use motives on weekends versus weekdays: Direct and indirect relations with cannabis use and related problems. (full – 2018)
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0306460318309134?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0306460318309134%3Fshowall%3Dtrue&referrer=https:%2F%2Feuropepmc.org%2Fabstract%2Fmed%2F30142485
Positive expectancies mediate the association between sensation seeking and marijuana outcomes in at-risk young adults: A test of the acquired preparedness model (full – 2018) https://onlinelibrary.wiley.com/doi/full/10.1111/ajad.12754
Social networks and substance use after transitioning into permanent supportive housing (full – 2018) https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0376871618303910?returnurl=null&referrer=null
Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256035/
Prevalence and predictors of alcohol and drug use among secondary school students in Botswana: a cross-sectional study. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302490/
The Implications of Cannabis Policy Changes in Washington on Adolescent Perception of Risk, Norms, Attitudes, and Substance Use. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295677/
Impulsivity, Sensation Seeking, and Decision-Making in Long-Term Abstinent Cannabis Dependent Patients. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300835/
The use of drugs and medical students: a literature review (full in English, abst in Portuguese – 2018) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018000500462&lng=en&nrm=iso&tlng=en
Co-use of tobacco and marijuana during pregnancy: Pathways to externalizing behavior problems in early childhood (link to PDF–2018)  https://www.researchgate.net/publication/326829079_Couse_of_tobacco_and_marijuana_during_pregnancy_Pathways_to_externalizing_behavior_problems_in_early_childhood
The “Jay-Dar” Phenomenon: Individuals Discriminate Cannabis Users from Nonusers
Based Upon a Photograph. (link to PDF – 2018)
https://www.researchgate.net/publication/326083593_The_JayDar_Phenomenon_Individuals_Discriminate_Cannabis_Users_from_Nonusers_Based_Upon_a_Photograph
Selective and Context-Dependent Social and Behavioral Effects of Δ9-
Tetrahydrocannabinol in Weakly Electric Fish. (download – 2018)
Selective and context-dependent social and behavioral effects of ∆9 …Examining effects of medical cannabis narratives on beliefs, attitudes, and intentions
related to recreational cannabis: A web-based randomized experiment (link to download–2018)  https://www.academia.edu/37489632/Examining_effects_of_medical_cannabis_narratives_on_beliefs_attitudes_and_intentions_related_to_recreational_cannabis_A_web-based_randomized_experiment
Perceived support for medical cannabis use among approved medical cannabis users in Canada (link to download – 2018) http://davidhammond.ca/wp-content/uploads/2018/03/2018-Medical-Cannabis-Perceptions-and-Support-Drug-Alc-Rev-Leos-Toro-et-al.pdf
Prenatal exposure to tobacco and cannabis: Effects on autonomic and emotion regulation (click “researchgate” for download – 2018)  https://scholar.google.com/scholar?q=Prenatal+exposure+to+tobacco+and+cannabis:+Effects+on+autonomic+and+emotion+regulation&hl=en&as_sdt=0&as_vis=1&oi=scholart
Marijuana: May 1968 (1968 article reprint-2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293403/
Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818300212?via%3Dihub
Characterizing Blunt Smokers by Their Acquisition of Cannabis. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29300122
Does social context matter? An ecological momentary assessment study of marijuana use among college students. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0306460318300042?via%3Dihub
Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818300510
Sacred Maya incense, copal (Protium copal – Burseraceae), has antianxiety effects in
animal models. (abst – 2018)  https://www.sciencedirect.com/science/article/pii/S037887411733965X?via%3Dihub
Risky sexual behavior among cannabis users: The role of protective behavioral strategies (abst–2018) https://www.sciencedirect.com/science/article/pii/S0306460318300522?via%3Dihub
Trajectory Classes of Cannabis Use and Heavy Drinking among Rural African American Adolescents: Multilevel Predictors of Class Membership. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29453937
Effects of CB1 receptor antagonism and stress exposures in adolescence on
socioemotional behaviours, neuroendocrine stress responses, and expression of relevant proteins in the hippocampus and prefrontal cortex in rats. (abst– 2018)
https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and
Repetitive Behavior. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29458998
Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex. (abst – 2018)
http://www.europeanneuropsychopharmacology.com/article/S0924-977X(18)30044-0/fulltext
The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29505682
Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and
problems in treatment-seeking cigarette smokers. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318301199
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs00520-018-4154-9
Young Urban Adolescents’ Activity Spaces, Close Peers, and the Risk of Cannabis Use:
A Social-Spatial Longitudinal Analysis. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29608124
Externalizing behavior problems are related to substance use in adolescents across six samples from Nordic countries. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs00787-018-1148-6
Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29624642
Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on
Zebrafish Larvae (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29634460
The Impact of Recreational Marijuana Legislation in Washington, DC on Marijuana Use Cognitions. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29652563
Marijuana use by intimate partners: Does discrepant use impair relationship functioning? (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29708362
Parental Divorce and Family History of Alcohol Disorder: Associations with Young
Adults’ Alcohol Problems, Marijuana Use, and Interpersonal Relations. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29693716
Psychosocial Correlates of Marijuana Use Among Pregnant and Non-Pregnant
Adolescent Girls (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29751095
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 (abst – 2018) https://www.nature.com/articles/s41386-018-0064-2
The Impact of the Urban Neighborhood Environment on Marijuana Trajectories During Emerging Adulthood (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29845401
Associations of Father’s Lifetime Cannabis Use Disorder with Child’s Initiation of
Cannabis Use, Alcohol Use, and Sexual Intercourse by Child Gender. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29847207Risk of criminal justice system involvement among people with co-occurring severe
mental illness and substance use disorder. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29852999
Cohabitation, Marijuana Use, and Heavy Alcohol Use in Young Adulthood.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29924679
Early Adolescent Substance Use and Mental Health Problems and Service Utilisation in a School-based Sample (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29929386
A Behavioral Economic Analysis of Marijuana and Other Drug Use Among Heavy
Drinking Young Adults. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29930973
Socio-ecological determinants of alcohol, tobacco, and drug use behavior of adolescents in Kilifi County at the Kenyan coast. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29944006
Co-use of cannabis, tobacco, and alcohol during adolescence: policy and regulatory
implications (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29944032
Differentiating the Drug Normalization Framework: A Quantitative Assessment of
Cannabis Use Patterns, Accessibility, and Acceptability Attitudes among University
Undergraduates (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29944057
A mediated multigroup model examining marijuana use consequences by sexual
orientation in us college students. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318306646
Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29974660
Developmental and behavioral effects in neonatal and adult mice following prenatal
activation of endocannabinoid receptors by capsaicin. (abst – 2018)
https://www.nature.com/articles/s41401-018-0073-z
Alcohol, Marijuana, and Dating Abuse Perpetration by Young Adults: Results of a Daily Call Study. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30037318
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (abst – 2018)
https://www.semanticscholar.org/paper/Risks-and-Benefits-of-Marijuana-Use%3A-A-National-of-KeyhaniSteigerwald/72d1820fcad2d5c86152febf95001935b5e11c56
Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues
behavioural alterations and brain atrophy in a mouse model of Rett syndrome.
(abst – 2018) https://www.sciencedirect.com/science/article/pii/S0028390818304131?via%3Dihub
Cigarette and Cannabis Use in Young Swiss Men: Examination of the Bidirectional,
Longitudinal Associations Between Frequency of Use and Descriptive Norms.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30079874Relationship of media exposure to substance use among adolescents in Saudi Arabia:
Results from a national study. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S037687161830142X
Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015. (abst – 2018)
http://journals.sagepub.com/doi/abs/10.1177/0020764018795213?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Effects of romantic involvement on substance use among young sexual and gender
minorities. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618304228
Affect and cannabis use in daily life: a review and recommendations for future research (abst–2018) https://www.sciencedirect.com/science/article/pii/S037687161830423X
Relative influence of perceived peer and family substance use on adolescent alcohol,
cigarette, and marijuana use across middle and high school. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0306460318306014?via%3Dihub
Marijuana Use, Marijuana Expectancies, and Hypersexuality among College Students (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30174385
Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior (abst–2018) https://www.sciencedirect.com/science/article/pii/S0892036218300242?via%3Dihub
Contributions of social influences and psychopathological factors to cannabis use and dependence in high-school students. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30308710
Interrelationships among depression, anxiety, flourishing, and cannabis use in youth (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318304301
The Effect of Medical Marijuana Laws on Marijuana-Related Attitude and Perception
Among US Adolescents and Young Adults. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs11121-018-0903-8
Addendum to “The Effect of Medical Marijuana Laws on Marijuana-Related Attitude
and Perception among US Adolescents and Young Adults”. (addendum – 2018)
https://link.springer.com/article/10.1007%2Fs11121-019-01001-9
Early Risk Factors for Daily Cannabis Use in Young Adults. (abst – 2018)
http://journals.sagepub.com/doi/abs/10.1177/0706743718804541?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cpab
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder
and Severe Behavioral Problems—A Retrospective Feasibility Study. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs10803-018-3808-2
Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use – A Natural Experiment. (abst – 2018)
https://jamanetwork.com/journals/jamapediatrics/article-abstract/2707906
More than just Alcohol: Marijuana and Illicit Drug Use at Parties Attended by 15-20
Year Olds (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/30395766
Developmental pathways of adolescent cannabis use: Risk factors, outcomes and sexspecific differences. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30395775
Maltreatment, attachment, and substance use in adolescence: Direct and indirect
pathways. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318308724?via%3Dihub
Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818308517?via%3Dihub
Disentangling longitudinal relations between youth cannabis use, peer cannabis use, and conduct problems: developmental cascading links to cannabis use disorder  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30457181
Changes over time in marijuana use, deviant behavior and preference for risky behavior among U.S. adolescents from 2002-2014: Testing the moderating effect of gender and age (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30461115
Exploring the relationship between polygenic risk for cannabis use, peer cannabis use, and the longitudinal course of cannabis involvement. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30474892
Instagram Participation and Substance Use Among Emerging Adults: The Potential Perils of Peer Belonging (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/30499697
Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal
cortical executive function and regulation of affective behaviors. (abst – 2018)
https://www.nature.com/articles/s41386-018-0282-7
Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs (abst–2018)  https://www.sciencedirect.com/science/article/abs/pii/S000579671830192X?via%3Dihub
Incarceration history, social network composition, and substance use among homeless youth in Los Angeles. (abst – 2018)  https://www.ncbi.nlm.nih.gov/pubmed/30592248
The Mediating Effect of Social Controls on Marijuana Use Among Adolescent Bullies,
Victims, and Bully-Victims: A Comparison of Various Approaches to Mediation (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30596307
The role of normative beliefs in the mediation of a school-based drug prevention
program: A secondary analysis of the #Tamojunto cluster-randomized trial (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322758/
Substance use behaviors and the timing of family formation during young adulthood (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380513/
Academic migration and marijuana use among undergraduate students: evidences from a sample in southern Brazil (full in English, abst in Portuguese – 2019)
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232019000803107&lng=en&nrm=iso&tlng=en
Typology of cannabis use among adults: A latent class approach to risk and protective factors. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318309237?via%3Dihub
Not getting high with a little help from your friends: Social versus drug network
correlates of marijuana use among YMSM. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318308244?via%3Dihub
Altered striatal reward processing in abstinent dependent cannabis users: Social context matters (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30658938
Marijuana use motives mediate the association between experiences of childhood abuse and marijuana use outcomes among emerging adults. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318309456?via%3Dihub
Context matters: Characteristics of solitary versus social cannabis use. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30779237
Religious Affiliation, Informal Participation, and Network Support Associated With
Substance Use: Differences Across Age Groups. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30786755
Reasons High School Students Use Marijuana: Prevalence and Correlations With Use
Across Four Decades (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30807270
Mummy, daddy, and addiction: Implicit insecure attachment is associated with substance use in college students (abst–2019)  https://www.ncbi.nlm.nih.gov/pubmed/30855152
Does morning affect contribute to daily Cannabis use? (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S030646031831339X?via%3Dihub
Substance use among individuals with mild intellectual disability or borderline
intellectual functioning in residential care: Examining the relationship between drinking motives and substance use. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30844128
Neighborhood context and transitions in marijuana use among urban young adults.
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30849926
Marijuana Use Episodes and Partner Intimacy Experiences: A Daily Report Study.
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30923794
Passion for Marijuana Use Mediates the Relations between Refusal Self-Efficacy and
Marijuana Use and Associated Consequences. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30947640
Is the Sum Greater than its Parts? Variations in Substance-Related Consequences by
Conjoint Alcohol-Marijuana Use Patterns. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31002291
Cross-cultural examination of college marijuana culture in five countries: Measurement invariance of the Perceived Importance of Marijuana to the College Experience Scale (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318314394?via%3Dihub
Variations in risk and promotive factors on substance use among urban American Indian youth. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31076018
Behavioral effects of chronic WIN 55,212-2 administration during adolescence and
adulthood in mice. (abst-2019) https://www.ncbi.nlm.nih.gov/pubmed/31120283
Threat Responsiveness as a Function of Cannabis and Alcohol Use Disorder Severity  (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31170004
Attitudes toward legalization of marijuana in the United States, 1986-2016: Changes in determinants of public opinion (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0955395919301628?via%3Dihub
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0889159119302806?via%3Dihub
Clarifying the Relation between Social Interaction Anxiety and Cannabis Use:
Personality as a Distinguishing Factor. (abst – 2019)
https://www.tandfonline.com/doi/abs/10.1080/10826084.2019.1626431?journalCode=isum20
Self-esteem, cultural identification, and substance use among American Indian youth (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31374591
Posting, texting, and related social risk behavior while high. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31382869
Parenting Practices in the Context of Legal Marijuana: Voices from Seattle Parents.
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31396007
Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoidmediated synaptic dysfunction in a valproic acid-induced rat model of Autism (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31398381
CB1 receptor antagonism in capuchin monkeys alters social interaction and aversive
memory extinction (abst–2019) https://link.springer.com/article/10.1007%2Fs00213-019-05305-0.
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling
markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia (abst–2019)  https://www.sciencedirect.com/science/article/pii/S027858461930106X?via%3Dihub
Role of the endocannabinoid system in neurological disorders. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0736574818302995?via%3Dihub
Association between cannabis use and sexual behavior among adolescents aged 12-
15 years in 21 low- and middle-income countries. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0306460319307373?via%3Dihub


SOCIAL ANXIETY
Social anxiety and cannabis cravings: The influences of parent injunctive norms and
tension reduction expectancies. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646225/
Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/
A longitudinal study of cannabis use initiation among high school students: Effects of
social anxiety, expectancies, peers and alcohol. (full – 2015)
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0140197115000457?returnurl=null&referrer=null
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147422/
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/
An Examination of Social Anxiety in Marijuana and Cigarette Use Motives Among
Adolescents. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851246/
Mediating Effects of Global Negative Effect Expectancies on the Association between
Problematic Cannabis Use and Social Anxiety. (full – 2017)
https://www.frontiersin.org/articles/10.3389/fpsyt.2017.00249/full
Four Mechanistic Models of Peer Influence on Adolescent Cannabis Use. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663303/
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349031/
Cannabis-Related Problems and Social Anxiety: The Mediational Role of Post-Event
Processing (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081747/
Characteristics of socially withdrawn youth in France: A retrospective study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28446040
Is there a role for cannabidiol in psychiatry? (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28112021
Mechanisms Underlying Sex Differences in Cannabis Use. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/29503790
The reasons for use of cannabinoids and stimulants in patients with schizophrenia.(links to full in English & Polish – 2018) http://psychiatriapolska.pl/261_273_S
Evidence for the use of “medical marijuana” in psychiatric and neurologic disorders.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007658/
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (full – 2018)  https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full
Cannabis use motives on weekends versus weekdays: Direct and indirect relations with cannabis use and related problems. (full – 2018)  https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0306460318309134?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0306460318309134%3Fshowall%3Dtrue&referrer=https:%2F%2Feuropepmc.org%2Fabstract%2Fmed%2F30142485
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test (link to PDF – 2018) https://www.ecnp.eu/presentationpdfs/70/P.4.c.008.pdf
Made from concentrate? A national web survey assessing dab use in the United States (link to PDF–2018)  https://www.researchgate.net/publication/325991896_Made_from_concentrate_A_national_web_survey_assessing_dab_use_in_the_United_States
Clinical and functional outcomes of cannabis use among individuals with anxiety
disorders: A 3-year population-based longitudinal study. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29486095
The therapeutic effects of Cannabis and cannabinoids: An update from the National
Academies of Sciences, Engineering and Medicine report. (abst – 2018)
http://www.ejinme.com/article/S0953-6205(18)30003-7/fulltext
Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and
problems in treatment-seeking cigarette smokers. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0306460318301199
The Interactive Influence of Social Anxiety and Experimentally Induced Postevent
Processing on Cannabis Use. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30035187
Shyness, social anxiety, social anxiety disorder, and substance use among normative
adolescent populations: A systematic review. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30422012
How effective and safe is medical cannabis as a treatment of mental disorders? A
systematic review (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30706168
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and
Potential. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
Clarifying the Relation between Social Interaction Anxiety and Cannabis Use:
Personality as a Distinguishing Factor. (abst – 2019)
https://www.tandfonline.com/doi/abs/10.1080/10826084.2019.1626431?journalCode=isum20CB1 receptor antagonism in capuchin monkeys alters social interaction and aversive memory extinction. (abst – 2019)
https://link.springer.com/article/10.1007%2Fs00213-019-05305-0.


SOCIAL MEDIA/INTERNET
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis.
(full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491148/
Twitter Chatter about Marijuana. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306811/
Cannabis Mobile Apps: A Content Analysis. (full – 2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705020/
Using Web searches to track interest in synthetic cannabinoids (aka ‘herbal incense’).
(full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412351/
“Time for dabs”: Analyzing Twitter data on marijuana concentrates across the U.S.  (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581982/
Online survey characterizing vaporizer use among cannabis users. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745650/
Displays of dabbing marijuana extracts on YouTube. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591851/
The Internet and drug markets (link to PDF – video – 2015)
https://www.semanticscholar.org/paper/The-Internet-and-drug-markets.-MounteneyBo/2b26d4dab5171bd4c05b1818c3668c7990976423
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Cannabis: a self-medication drug for weight management? The never ending story.
(abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26456495
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full – 2016) http://www.jmir.org/2016/9/e252/
Ecological Momentary Assessment and Smartphone Application Intervention in
Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study
Protocol (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
“When ‘Bad’ is ‘Good'”: Identifying Personal Communication and Sentiment in Drug Related Tweets. (full – 2016) http://publichealth.jmir.org/2016/2/e162/
“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on
Cannabis Use and ADHD (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614
A content analysis of tweets about high-potency marijuana. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983477/
Marijuana-Related Posts on Instagram. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939096/
Digital Interventions for Problematic Cannabis Users in Non-Clinical Settings: Findings from a Systematic Review and Meta-Analysis. (full – 2016)
http://www.karger.com/Article/FullText/445716
Exploring Marijuana Advertising on Weedmaps, a Popular Online Directory.
(full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247325/
Examination of YouTube videos related to synthetic cannabinoids. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315684/
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S.
(full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893972/
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data. (link to PDF – 2016) https://www.researchgate.net/publication/307970354_Buying_drugs_on_a_Darknet_market_A_better_deal_Studying_the_online_illicit_drug_market_through_the_analysis_of_digital_physical_and_chemical_data
From “herbal highs” to the “heroin of cannabis”: Exploring the evolving discourse on
synthetic cannabinoid use in a Norwegian Internet drug forum (link to download–2016) https://www.semanticscholar.org/paper/From-%22herbal-highs%22-to-the-%22heroin-of-cannabis%22%3A-on-Bilgrei/964e732f95525e946b6f9b2be820fa201f52cce6
Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana (abst – 2016) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1135158
Marijuana: Views on Its Medical Use Recorded at the Slovak Social Network.
(abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27282988
Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use. (abst – 2016)
https://www.semanticscholar.org/paper/Assessing-the-Validity-of-Online-Drug-Forums-as-a-PaulChisolm/3ac0006f318a35be541605769bd767eb00e8af6b
The Synthetic Cannabinoids Phenomenon. (abst – 2016)
http://www.ncbi.nlm.nih.gov/pubmed/27655416
“It Takes Longer, but When It Hits You It Hits You!”: Videos About Marijuana Edibles
on YouTube. (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502544/
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An
Australia-Centered Study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California (full – 2017) http://www.jmir.org/2017/7/e236/
Medical Decision-Making Processes and Online Behaviors Among Cannabis Dispensary Staff (full – 2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570116/
Increased in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545681/
Utilizing Big Data and Twitter to Discover Emergent Online Communities of Cannabis Users (full–2017)  http://journals.sagepub.com/doi/full/10.1177/1178221817711425
Acceptability and effectiveness of a web-based psychosocial intervention among criminal
justice involved adults. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346353/
Characterizing marijuana concentrate users: A web-based survey. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567791/
“Retweet to Pass the Blunt”: Analyzing Geographic and Content Features of CannabisRelated Tweeting Across the United States. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668996/
“I feel like I’ve hit the bottom and have no idea what to do”: Supportive social networking on Reddit for individuals with a desire to quit cannabis use. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143175/
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship? (link to PDF – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Legal+cannabis+laws%2C+home+cultivation%2C+and+use+of+edible+cannabis+products%3A+A+growing+relationship%3F&btnG=
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based
investigation. (link to PDF – 2017)
https://www.researchgate.net/publication/318332922_Cannabis_use_in_people_with_Parkinson’s_disease_and_Multiple_Sclerosis_A_web-based_investigation
“You got to love rosin: Solventless dabs, pure, clean, natural medicine.” Exploring
Twitter data on emerging trends in Rosin Tech marijuana concentrates (link to download–2017)  https://www.academia.edu/35654389/Drug_and_Alcohol_Dependence_You_got_to_love_rosin_Solventless_dabs_pure_clean_natural_medicine._Exploring_Twitter_data_on_emerging_trends_in_Rosin_Tech_marijuana_concentrates
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency
cannabis concentrate (click “bath.ac” for download – 2017)  https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=User+characteristics+and+effect+profile+of+Butane+Hash+Oil%3A+An+extremely+high-potency+cannabis+concentrate&btnG=
Comparison of brief versus extended personalised feedback in an online intervention for cannabis users: Short-term findings of a randomised trial (abst–2017) https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30294-X/fulltext
The illegal synthetic cannabinoid drug market in Israel – evolution and new challenges (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28530077
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
A market on both “sides” of the law: The use of the hidden web for the sale of new
psychoactive substances (abst–2017) https://www.semanticscholar.org/paper/A-market-on-both-%22sides%22-of-the-law%3A-The-use-of-the-WadsworthDrummond/05013fb35e20c1810001d8aa2c024706ecb0113e
Online self-help forums on cannabis: A content assessment. (abst – 2017)
https://www.sciencedirect.com/science/article/pii/S0738399117303452
Exposure to and Content of Marijuana Product Reviews. (abst – 2017)
https://link.springer.com/article/10.1007%2Fs11121-017-0818-9
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use in older adults with and without HIV infection. (abst – 2017)
https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
The efficacy of computerized interventions to reduce cannabis use: A systematic review and meta-analysis. (abst – 2017)
https://www.sciencedirect.com/science/article/pii/S0306460317304537?via%3Dihub
The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial (full–2018) http://www.researchprotocols.org/2018/1/e30/
Studying Cannabis Use Behaviors With Facebook and Web Surveys: Methods and
Insights (full–2018) http://publichealth.jmir.org/2018/2/e48/
Cannabis and Kratom online information in Thailand: Facebook trends 2015–2016  (full–2018) https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-018-0155-4
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort (full–2018) https://link.springer.com/article/10.1186/s10194-018-0862-2
Marijuana promotions on social media: adolescents’ views on prevention strategies.
(full – 2018) https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-018-0152-7
Rolling and scrolling: The portrayal of marijuana cigars (blunts) on YouTube (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991612/
Gaming under the influence: An exploratory study. (full – 2018)
https://akademiai.com/doi/full/10.1556/2006.7.2018.27
Tracking Health Related Discussions on Reddit for Public Health Applications (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977623/
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under
Naturalistic Conditions. (full – 2018) http://www.mdpi.com/2305-6320/5/3/75/htm
Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps. (full – 2018)
http://www.mdpi.com/2076-3425/8/7/123/htmEffects of Treatment Length and Chat-Based Counseling in a Web-Based Intervention for Cannabis Users: Randomized Factorial Trial. (full – 2018) http://www.jmir.org/2018/5/e166/
Perceived Attitudes About Substance Use in Anonymous Social Media Posts Near
College Campuses: Observational Study. (full – 2018)
https://mental.jmir.org/2018/3/e52/
Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. (full – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30157131
Initiation of vaporizing cannabis: Individual and social network predictors in a
longitudinal study of young adults. (full – 2018)
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0376871618302746?returnurl=null&referrer=null
Social Media Posts by Recreational Marijuana Companies and Administrative Code
Regulations in Washington State. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324592/
Online Sales of Marijuana: An Unrecognized Public Health Dilemma. (link to PDF – 2018) https://www.researchgate.net/publication/323937873_Online_Sales_of_Marijuana_An_Unrecognized_Public_Health_Dilemma
Made from concentrate? A national web survey assessing dab use in the United States (link to PDF – 2018) https://www.researchgate.net/publication/325991896_Made_from_concentrate_A_national_web_survey_assessing_dab_use_in_the_United_States
Spiritual belief and its link with potentially addictive behaviors in a youth sample in
Switzerland (click “unilch” for download of full in English & abst in French – 2018)
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Spiritual+belief+and+its+link+with+potentially+addictive+behaviors+in+a+youth+sample+in+Switzerland.&btnG
Examining effects of medical cannabis narratives on beliefs, attitudes, and intentions related to recreational cannabis: A web-based randomized experiment  (link to download–2018)  https://www.academia.edu/37489632/Examining_effects_of_medical_cannabis_narratives_on_beliefs_attitudes_and_intentions_related_to_recreational_cannabis_A_web-based_randomized_experiment
Green tongue phenomenon, or diagnosis via Google (abst in English & French– 2018) http://www.em-consulte.com/article/1220732/alertePM
Efficacy of a Web-Based Tailored Intervention to Reduce Cannabis Use Among Young
People Attending Adult Education Centers in Quebec. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29466093
Combustible and Electronic Tobacco and Marijuana Products in Hip-Hop Music Videos, 2013-2017. (abst – 2018)  https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2706175
Leveraging user perspectives for insight into cannabis concentrates. (abst – 2018)
https://www.tandfonline.com/doi/full/10.1080/00952990.2018.1436179
The Impact of Recreational Marijuana Legislation in Washington, DC on Marijuana Use Cognitions. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29652563A Twitter-based survey on marijuana concentrate use (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618301984
A pilot trial of text-delivered peer network counseling to treat young adults with cannabis use disorder. (abst – 2018)  https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30477-4/fulltext
Marijuana Promotion Online: an Investigation of Dispensary Practices. (abst – 2018)
https://www.semanticscholar.org/paper/Marijuana-Promotion-Online%3A-an-Investigation-of-Cavazos-RehgKrauss/e23d497ee8e0c72a3b1c93a1d2aa0bdc4047a345
Media portrayal of prenatal and postpartum marijuana use in an era of scientific
uncertainty. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618301832
Parental Restriction of Movie Viewing Prospectively Predicts Adolescent Alcohol and
Marijuana Initiation: Implications for Media Literacy Programs. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs11121-018-0891-8
Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings (abst–2018) https://www.sciencedirect.com/science/article/pii/S0376871618302424
On the use of digital technologies to reduce the public health impacts of cannabis
legalization in Canada. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30097890
Relationship of media exposure to substance use among adolescents in Saudi Arabia:
Results from a national study. (abst – 2018)  https://www.sciencedirect.com/science/article/pii/S037687161830142X
Young adults’ perceptions of acceptability and effectiveness of a text message-delivered treatment for cannabis use disorder. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0740547218302307
A Longitudinal Investigation of Associations Between Marijuana Displays on Facebook and Self-Reported Behaviors Among College Students. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30238892
Marijuana eCHECKUPTO GO: Effects of a personalized feedback plus protective
behavioral strategies intervention for heavy marijuana-using college students.
(abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618303351
The Influence of Online-Only Friends on the Substance Use of Young Adults with a
History of Childhood Maltreatment. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30372360
Content, Exposure, and Effects of Public Discourses about Marijuana: A Systematic
Review. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30395785
Medical cannabis: A needs analysis for people with epilepsy. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S1744388118302354?via%3Dihub
Marijuana Promotion Online: an Investigation of Dispensary Practices. (abst – 2018)https://www.semanticscholar.org/paper/Marijuana-Promotion-Online%3A-an-Investigation-of-Cavazos-RehgKrauss/e23d497ee8e0c72a3b1c93a1d2aa0bdc4047a345
Instagram Participation and Substance Use Among Emerging Adults: The Potential Perils of Peer Belonging (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/30499697
US Veterinarians’ Knowledge, Experience, and Perception Regarding the Use of
Cannabidiol for Canine Medical Conditions. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338022/
Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients (full–2019)
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0278-6
The Association between Cannabis Product Characteristics and Symptom Relief (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389973/
Using Twitter to Understand the Human Bowel Disease Community: Exploratory
Analysis of Key Topics. (full – 2019) https://www.jmir.org/2019/8/e12610/
Feasibility and Acceptability of e-Screening and Brief Intervention and Tailored Text
Messaging for Marijuana Use in Pregnancy. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30657434
How and why have attitudes about cannabis legalization changed so much?
(abst – 2019) https://www.sciencedirect.com/science/article/pii/S0049089X17310232?via%3Dihub
Attitudes toward and knowledge of medical cannabis among individuals with spinal cord injury. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30675390
Exploring the components of an efficacious computer brief intervention for reducing
marijuana use among adults in the emergency department. (abst – 2019)
https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(18)30381-7/fulltext
Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization? (abst–2019)  https://www.sciencedirect.com/science/article/abs/pii/S0955395919300131?via%3Dihub
Brief report: Characterization of marijuana use in us college students by state marijuana legalization status as reported to an online survey. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30901123
Characterising KandyPens-related posts to Instagram: implications for nicotine and
cannabis use. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31147484
Making “Weedish Fish”: An Exploratory Analysis of Cannabis Recipes on Pinterest.
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31298112
Posting, texting, and related social risk behavior while high. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31382869Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center. (abst – 2019)
https://www.epilepsybehavior.com/article/S1525-5050(19)30538-4/fulltext
The effectiveness of self-directed medical cannabis treatment for pain. (abst – 2019)
https://www.sciencedirect.com/science/article/abs/pii/S0965229919308040


SPACEFLIGHT/OUTER SPACE
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3
Sex differences in stress and immune responses during confinement in Antarctica  (full–2019) https://bsd.biomedcentral.com/articles/10.1186/s13293-019-0231-0
Stress Related Shift Toward Inflammaging in Cosmonauts After Long-Duration Space
Flight (full–2019) https://www.frontiersin.org/articles/10.3389/fphys.2019.00085/full


SPASTICITY*+
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Cortico-spinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
top

Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015)
http://jama.jamanetwork.com/article.aspx?articleid=2338251
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015)  http://cannabisclinicians.org/wp-content/uploads/2015/07/JAMA-Chronic-Pain-2015.pdf
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507161/
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230

Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25208898
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796592
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26126926
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cannabinoids for the Treatment of Movement Disorders (abst–2015)
https://link.springer.com/article/10.1007%2Fs11940-015-0370-5
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Use of Cannabinoids for Spasticity and Pain Management in MS (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26705757

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis  Spasticity in Italy: First Data from a Large Observational Study (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26571097
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26289497
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life  Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Walking improvements with nabiximols in patients with multiple sclerosis (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26239223
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710104/
top

THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms (full–2016) http://www.karger.com/Article/FullText/444235
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain (full–2016) http://www.karger.com/Article/FullText/444234
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity (full–2016) http://jnnp.bmj.com/content/early/2016/05/08/jnnp-2015-312591.long
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
The use of medical-grade cannabis in patients non-responders to Nabiximols (first page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26750641
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27003093
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27160412
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30056-6/abstract
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis (abst in English & Spanish–2016) http://www.elsevier.es/es-revista-enfermeria-clinica-35-articulo-manejo-los-sintomas-asociados-espasticidad-S1130862116300882
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray (abst–2016) http://www.jns-journal.com/article/S0022-510X(16)30620-7/fulltext
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) http://www.eurekaselect.com/146891/article
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27660328
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of  THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016)  https://www.karger.com/Article/Abstract/445943
Muscle elastography: a new imaging technique for multiple sclerosis spasticity  measurement (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27904961
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey  Community Engagement Project (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD  oromucosal spray efficacy as an add-on therapy for post-stroke spasticity (full–2017) http://bmjopen.bmj.com/content/7/9/e016843.long
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Cannabis use in persons with traumatic spinal cord injury in Denmark (full-2017) https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2105
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis:  Rationale, study design, and methodology (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704890/
Systematic review of safeness and therapeutic efficacy of cannabis in patients with  multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29119763 (full in Italian)  http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabisEffects
on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-
Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189366
Cannabinoids therapeutic use: what is our current understanding following the  introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28276775
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28929471
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study (abst–2017)  https://link.springer.com/article/10.1007%2Fs10072-017-3148-6
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29055461
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29067992
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791
Cannabidiol to Improve Mobility in People with Multiple Sclerosis. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fneur.2018.00183/full#B19
The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943754/
Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with
Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked
Potentials. (full – 2018) http://www.mdpi.com/2305-6320/5/3/59/htm
Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice. (link to PDF – 2018)
http://biomed.papers.upol.cz/artkey/bio-201801-
0003_medical_cannabis_in_the_treatment_of_cancer_pain_and_spastic_conditions_and_options_of_drug_delivery_in_clinica.php
Practical considerations in medical cannabis administration and dosing (link to PDF–2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a
Systematic Review of Reviews (click “usyd” for download– 2018)
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+Use+of+Cannabis+and+Cannabinoids+in+Treating+Symptoms+of+Multiple+Sclerosis%3A+a+Systematic+Review+of+Reviews.+&btnG=
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29524396
The therapeutic effects of Cannabis and cannabinoids: An update from the National
Academies of Sciences, Engineering and Medicine report. (abst – 2018)
http://www.ejinme.com/article/S0953-6205(18)30003-7/fulltextClinical response to Nabiximols correlates with the down-regulation of immune pathways
in Multiple Sclerosis. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29528549
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/0883073818773028?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Cannabinoids for Treatment of MS Symptoms: State of the Evidence. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs11910-018-0859-x
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for
Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a
Systematic Review. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369421/
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot
open-label study. (full – 2019)
https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot
open-label study. (full – 2019)
https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader
Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey  (1st page–2019) https://www.deepdyve.com/lp/springer-journal/cannabis-use-in-myotonic-dystrophy-patients-in-germany-and-usa-a-pilotmaEwTVPdeX?key=bioportfolio
Interim analysis of the survey accompanying insurance-covered prescriptions of
cannabis-based medicines in Germany (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02968-0
Progress in cannabis research from a pharmaceutical chemist’s point of view. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02964-4
Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany)
(abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3
Illegal cannabis use is common among Danes with multiple sclerosis. (abst – 2019)
https://www.msard-journal.com/article/S2211-0348(19)30212-3/fulltext
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol
(CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. (abst – 2019)  https://www.sciencedirect.com/science/article/pii/S0889159119306476?via%3Dihub


SPINAL CORD INJURY*+
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13324/full
Cannabinoids to treat spinal cord injury (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000573
CB 1Cannabinoid Receptor Agonist Inhibits Matrix Metalloproteinase Activity in Spinal Cord Injury: A Possible Mechanism of Improved Recovery (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0304394015002979
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (link to PDF–2016) https://www.dovepress.com/a-preliminary-evaluation-of-the-relationship-of-cannabinoid-blood-conc-peerreviewed-article-JPR
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394015303517
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the bloodspinal cord barrier permeability induced by ischemia-reperfusion injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26835555
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450568
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484302
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27589093
Cannabis use in persons with traumatic spinal cord injury in Denmark (link to PDF- 2017) https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2105
Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in  Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation  and Upregulation of CB1 and CB2 Receptors (full–2017)  https://www.karger.com/Article/FullText/484460
Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107590
Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe  spinal cord injury (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28479140
The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via  inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28716633
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience (abst in English – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28929471 (abst in Spanish – 2017) https://www.neurologia.com/articulo/2017118
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway (link to PDF – 2017)  https://www.researchgate.net/publication/320213560_Photobiomodulation_Therapy_Improves_Acute_Inflammatory_Response_in_Mice_the_Role_of_Cannabinoid_ReceptorsATP-Sensitive_K_Channelp38-MAPK_Signalling_Pathway
Cannabinoids and spinal cord stimulation for the treatment of failed back surgery
syndrome refractory pain. (full – 2018) https://www.dovepress.com/cannabinoids-and-spinal-cord-stimulation-for-the-treatment-of-failed-b-peer-reviewed-fulltext-article-JPR
Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081457/
Cannabis cures the spine. (article – 2018) https://www.jtcvs.org/article/S0022-5223(18)32080-4/fulltext
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29524396
The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice (abst – 2018)  https://www.sciencedirect.com/science/article/abs/pii/S0008874918300911
The enigma of cannabis use in spinal cord injury. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30109134Inhibiting a spinal cord signaling pathway protects against ischemia injury in rats (abst – 2018) https://www.sciencedirect.com/science/article/pii/S002252231832035X
Attitudes toward and knowledge of medical cannabis among individuals with spinal cord injury (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30675390
Survey on current treatments for pain after spinal cord damage. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30729038


SPINAL MANIPULATIVE THERAPY
Role for Endocannabinoids in Spinal Manipulative Therapy Analgesia? (full – 2019)
https://www.hindawi.com/journals/ecam/2019/2878352/


SPINOCEREBELLAR ATAXIA/SCA
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3 (abst–2016)
https://www.sciencedirect.com/science/article/abs/pii/S0306452216305012
Altered striatal endocannabinoid signaling in a transgenic mouse model of
spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets (full–2019)
https://www.frontiersin.org/articles/10.3389/fnmol.2019.00094/full
top


SPLEEN*+
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490613/
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation (abst–2015) http://www.sciencedirect.com/science/article/pii/S1098882315300125
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator  constitutively secreted by adrenals and in liver upon tissue damage (full–2017)  https://www.nature.com/articles/s41598-017-09808-8
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the  intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by  D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem  Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
FAAH, but not MAGL, inhibition modulates acute TLR3-induced neuroimmune signaling in the rat, independent of sex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28726298
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following  Developmental Chlorpyrifos Exposure in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28820005
CB2 receptor antibody signal specificity: correlations with the use of partial CB2-
knockout mice and anti-rat CB2 receptor antibodies. (link to PDF – 2018)
https://www.researchgate.net/publication/326120461_CB_2_receptor_antibody_signal_specificity_correlations_with_the_use_of_partial_CB_2_-knockout_mice_and_anti-rat_CB_2_receptor_antibodies
Host and helminth-derived endocannabinoids are generated during infection with effects on host immunity. (link to PDF – 2018) https://www.researchgate.net/publication/326996437_Host_and_helminthderived_endocannabinoids_are_generated_during_infection_with_effects_on_host_immunity
2-AG limits Theiler’s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs. (abst – 2018)  https://www.ncbi.nlm.nih.gov/pubmed/29484707
The inhibition of CB1 receptor accelerates the onset and development of EAE possibly by regulating microglia/macrophages polarization. (abst – 2018)
https://www.sciencedirect.com/science/article/abs/pii/S0165572817304678
Broad Lipidomic and Transcriptional Changes of Prophylactic PEA Administration in
Adult Mice (full–2019)  https://www.frontiersin.org/articles/10.3389/fnins.2019.00527/full


SPORTS
Annual banned-substance review: analytical approaches in human sports drug testing (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/dta.1769/full
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions (abst–2015) http://link.springer.com/article/10.1007/s40279-015-0362-3
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27191966
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945387/
Prevalence and correlates of cannabis use among athletes-A systematic review (link to download–2016)  https://www.researchgate.net/publication/308173146_Prevalence_and_correlates_of_cannabis_use_among_athletesA_systematic_review
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a  Representative Sample of High School Students (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27191966
Cannabis: Exercise performance and sport. A systematic review (full–2017)  http://www.jsams.org/article/S1440-2440(17)30342-0/fulltext
Gender-specific associations between involvement in team sport culture and canadian  adolescents’ substance-use behavior (full–2017)  https://www.sciencedirect.com/science/article/pii/S2352827317301398?via%3Dihub
Cannabis and the Health and Performance of the Elite Athlete. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116792/Changes and specificities in health behaviors among healthcare students over an 8-year period (full–2018)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194188
Self-Reported Use and Attitudes Toward Performance-Enhancing Drugs in
Ultramarathon Running (abst – 2018)  https://www.ncbi.nlm.nih.gov/pubmed/30227921
Endocannabinoids, exercise, pain, and a path to health with aging. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0098299718300359?via%3Dihub
Cannabis use in active athletes: Behaviors related to subjective effects. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598761/
Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review (abst–2019) https://bjsm.bmj.com/content/53/12/754.long


STEM CELLS/PROGENITOR CELLS+
Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells (full–2015) http://www.hindawi.com/journals/bmri/2015/874982/
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways (full–2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
Inhibition of FAAH confers increased stem cell migration via PPARα (full-2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583083/
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Cannabinoid Receptor‐2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P‐Selectin Activity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781665/
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016)  http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=7042&path%5b%5d=20008
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297661/
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028843
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301277
Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates distinct cellular pools; implications for endocannabinoid signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S104474311630135X
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
Activation of cannabinoid receptor type II by AM1241 protects adipose-derived
mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630296/
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta adrenergic  stimulation (full–2017) http://www.exphem.org/article/S0301-472X(17)30813-5/fulltext
Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-
radiation and small molecule inhibitors of cell signaling pathways (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650324/
Restoration of osteogenic differentiation by overexpression of cannabinoid receptor 2 in bone marrow mesenchymal stem cells isolated from osteoporotic patients (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729701/
Decisive role of P42/44 mitogen-activated protein kinase in Δ9-tetrahydrocannabinol induced migration of human mesenchymal stem cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739695/
Neuroprotective properties of endocannabinoids N-arachidonoyl dopamine and Ndocosahexaenoyl dopamine examined in neuronal precursors derived from human pluripotent stem cells (2 pages–2017)  https://link.springer.com/article/10.1134%2FS0006297917110141
Alterations of the hematologic cells in synthetic cannabinoid users (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28169460
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem  Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
Expression of Type I Cannabinoid Receptors at Different Stages of Neuronal  Differentiation of Human Fibroblasts (abst–2017)  https://link.springer.com/article/10.1007%2Fs10517-017-3782-2
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27778331
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived  Neurons (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29230395
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/
Anti-invasion Effects of Cannabinoids Agonist and Antagonist on Human Breast Cancer Stem Cells (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843309/
Infectious risks associated with medicinal Cannabis: Potential implications for
immunocompromised patients? (link to PDF–2018)
https://www.researchgate.net/publication/322990000_Infectious_risks_associated_with_medicinal_Cannabis_Potential_implications_for_immunocompromised_patients
N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of
docosahexaenoic acid (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0098299718300244
Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29888782Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0014482718304312?via%3Dihub
Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Cellular Model of Dravet Syndrome (download–2019) http://symposium.cshlp.org/content/early/2019/06/11/sqb.2018.83.038174.long


STORAGE of CANNABIS/CANNABINOIDS
Impact of oral fluid collection device on cannabinoid stability following smoked  cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282833/
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal  cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00285/full#B14
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0731708516302722
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible  Brownies (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798074
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27420392
Chapter 5 – Quality Control and Stability Assessment (abst–2016)  http://www.sciencedirect.com/science/article/pii/B9780128046463000059
Evaluation of long-term stability of cannabinoids in standardized preparations of  cannabis flowering tops and cannabis oil by ultra-high-performance liquid
chromatography tandem mass spectrometry (full–2017)  https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2017-0758/cclm-2017-0758.xml
Evaluation of long-term stability of cannabinoids in standardized preparations of
cannabis flowering tops and cannabis oil by ultra-high-performance liquid
chromatography tandem mass spectrometry. (1st page– 2017)
https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2017-0758/cclm-2017-0758.xml
Air Quality Inside Police Drug Safes and Drug Storage Areas. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29462320
The role of time and storage conditions on the composition of hashish and marijuana samples: A four-year study. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0379073818308818?via%3Dihub
Long-term medical cannabis use and risk factors for diversion: report on physician’s
guidance and patients’ behaviour (abst–2019)  https://www.ncbi.nlm.nih.gov/pubmed/31190678
Effects of long term storage on secondary metabolite profiles of cannabis resin (abst–2019) https://www.sciencedirect.com/science/article/pii/S0379073819302191?via%3Dihub
Cannabis in homes with children: use and storage practices in a legalised state (Colorado) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31371385


STRAIN INFORMATION
Characterisation of cannabinoid composition in a diverse Cannabis sativa L. germplasm collection (full–2015)  http://link.springer.com/article/10.1007/s10681-015-1585-y
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L. (abst–2015)  https://link.springer.com/article/10.1007%2Fs12010-014-1435-8
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana) (abst–2015) http://link.springer.com/article/10.1007/s10722-015-0254-2
Cannabis species and cannabinoid concentration preference among sleep-disturbed
medicinal cannabis users (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26151582
Two complete chloroplast genome sequences of Cannabis sativa varieties (abst–2015) http://informahealthcare.com/doi/abs/10.3109/19401736.2015.1053117
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965456/
The Name of Cannabis: A Short Guide for Nonbotanists (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531363/
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety
exposed to salinity (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120038/
Medical Marijuana for Epilepsy? (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911937/
Pain, Cannabis Species, and Cannabis Use Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172585
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9-
Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436332/
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol  and Cannabidiol on Human Cognition (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435777/
The Bibenzyl Canniprene Inhibits the Production of Pro-Inflammatory Eicosanoids and  Selectively Accumulates in Some Cannabis sativa Strains (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.6b01126
Recommendation to reconsider examining cannabis subtypes together due to opposing  effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
Differentiation of Cannabis subspecies by THCA synthase gene analysis using RFLP  (abst–2017) http://www.jflmjournal.org/article/S1752-928X(17)30104-X/fulltext
Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of  Cannabis sativa Using GC-FID (abst–2017)  https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-124088
The crop-residue of fiber hemp cv. Futura 75: from a waste product to a source of
botanical insecticides. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/29105041
Differentiation of Cannabis subspecies by THCA synthase gene analysis using RFLP.
(abst – 2017) http://www.jflmjournal.org/article/S1752-928X(17)30104-X/fulltext
The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. (full – 2018)
https://www.nature.com/articles/s41598-018-22755-2
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort (full – 2018) https://link.springer.com/article/10.1186/s10194-018-0862-2
A Novel Observational Method for Assessing Acute Responses to Cannabis: Preliminary Validation Using Legal Market Strains (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870063/
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under
Naturalistic Conditions (full – 2018)
http://www.mdpi.com/2305-6320/5/3/75/htm
Accumulation of bioactive metabolites in cultivated medical Cannabis. (full – 2018)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201119
Chemometric Analysis of Cannabinoids: Chemotaxonomy and Domestication Syndrome (full – 2018) https://www.nature.com/articles/s41598-018-31120-2
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with
schizophrenia. (full – 2018)
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0253-7
Cannabis and the Anxiety of Fragmentation-A Systems Approach for Finding an
Anxiolytic Cannabis Chemotype. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204402/
Cannabis Systematics at the Levels of Family, Genus, and Species. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225593/
Cannabis in palliative care: current challenges and practical recommendations.
(full – 2018) http://apm.amegroups.com/article/view/20097/21242
Erratum to cannabis in palliative care: current challenges and practical recommendations (erratum–2018) http://apm.amegroups.com/article/view/23880/23545
Cannabis Oil in an Irish Children’s Critical Care Unit. (full – 2018)
http://imj.ie/cannabis-oil-in-an-irish-childrens-critical-care-unit/
A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/The Anti-Inflammatory Properties of Terpenoids from Cannabis. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308289 /
Latitudinal Adaptation and Genetic Insights Into the Origins of Cannabis sativa L.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309158/
An experimental randomized study on the analgesic effects of pharmaceutical-grade
cannabis in chronic pain patients with fibromyalgia. (link to PDF – 2018)
https://www.researchgate.net/publication/329902313_An_experimental_randomized_study_on_the_analgesic_effects_of_pharmaceuti
cal-grade_cannabis_in_chronic_pain_patients_with_fibromyalgia
Consumer perceptions of strain differences in Cannabis aroma.
(link to download – 2018) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192247
CMA position against separate regulations for medical cannabis draws ire and insults (article – 2018) http://www.cmaj.ca/content/190/18/E574.long
Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on
Zebrafish Larvae. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29634460
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and
Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30152161
13-loci STR multiplex system for Brazilian seized samples of marijuana:
individualization and origin differentiation. (abst – 2018)
https://www.semanticscholar.org/paper/13-loci-STR-multiplex-system-for-Brazilian-seized-FettMariot/7a7e96b0fbe47a0a8ed9b43950f4663821603e0e
Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0367326X17317598?via%3Dihub
Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An
explorative study. (abst – 2018)  https://www.sciencedirect.com/science/article/abs/pii/S0034528818313158?via%3Dihub
The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain. (full – 2019)  https://www.frontiersin.org/articles/10.3389/fpls.2018.01969/full
Phenotypic plasticity influences the success of clonal propagation in industrial
pharmaceutical Cannabis sativa. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422331/
Use of 13C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in
Fibre-Type Cannabis sativa L. (Hemp). (full – 2019)
https://www.mdpi.com/1420-3049/24/6/1138/htm
Cannabis used in US research differs genetically to the varieties people smoke.
(full – 2019) https://www.nature.com/articles/d41586-019-01415-z
Terpenes in Cannabis sativa – From plant genome to humans. (full – 2019)
https://www.sciencedirect.com/science/article/pii/S0168945219301190?via%3DihubGene Networks Underlying Cannabinoid and Terpenoid Accumulation in Cannabis (link to PDF – 2019) http://www.plantphysiol.org/content/early/2019/05/28/pp.18.01506.long
The Terroir of Cannabis: Terpene Metabolomics as a Tool to Understand Cannabis sativa Selections (link to 1st page – 2019) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-0915-2550
Promoting cannabis products to pharmaceutical drugs. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/30851400
Whole Plastome Sequences of Two Drug-Type Cannabis: Insights Into the Use of Plastid in Forensic Analyses (abst–2019)  https://www.ncbi.nlm.nih.gov/pubmed/31411746


STRESS+
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517601/
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (full–2015)  http://ijnp.oxfordjournals.org/content/18/8/pyv005.long
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/04/ijnp.pyv095.long
Targeting the endocannabinoid system to treat anxiety-related disorders (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0058/jbcpp-2015-0058.xml
Cannabis–the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
top
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling (full–2015)  http://www.cell.com/neuron/fulltext/S0896-6273(15)00130-0
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long
Mechanisms of stress in the brain (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700831/
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522350/
Neurobiological Interactions Between Stress and the Endocannabinoid System (full–2015) http://www.nature.com/npp/journal/v41/n1/full/npp2015166a.html
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Maternal separation and early stress cause long-lasting effects on dopaminergic and
endocannabinergic systems and alters dendritic morphology in the nucleus accumbens  and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats  (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793117/
Endocannabinoid signaling in the stress response of male and female songbirds (full–2015) http://press.endocrine.org/doi/10.1210/en.2015-1425?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Endocannabinoid signaling integrates multiple stress hormone effects on memory (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal Accumbens Plasticity after Stress (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748431/
Behavioral genetics: of mice, men, and internal bliss (full–2015)  http://www.cell.com/current-biology/fulltext/S0960-9822(15)00414-5
The endocannabinoid system in guarding against fear, anxiety and stress (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26585799
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25581607
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715000283
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001047
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001023
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815002168
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0091305715001185
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0278584615000986
Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic pituitary-adrenal axis and other consequences of daily repeated stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092203
Stress-related synaptic plasticity in the hypothalamus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26087679
top
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Abnormalities in neuroendocrine stress response in psychosis: the role of endo-cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370602
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26391492
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300959
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26552023
Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26609670
Endocannabinoid Regulation of Neuroendocrine Systems (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638767
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638768
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708929
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among  Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Mediating processes between stress and problematic marijuana use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661989
The maternal deprivation animal model revisited (abst–2015) http://www.sciencedirect.com/science/article/pii/S0149763415000172
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000068
Simultaneous determination of endocannabinoids in murine plasma and brain  substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0731708515001946
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
2-arachidonoylglycerol signaling impairs short-term fear extinction (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201626a.html
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses (full–2016) http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201622a.html
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress (full–2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30851-8
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Impaired Ethanol- Induced Sensitization and Decreased Cannabinoid Receptor-1 in a  Model of Posttraumatic Stress Disorder (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871361/
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related  Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00454/full
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
top
Endocannabinoids in Cerebrovascular Regulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865067/
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid  Release in the Basolateral Amygdala (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978804/
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and (+/+)
mice (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937884/
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of  memory consolidation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055136/
Acute effects of cannabis on breath-holding duration (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965168/
Variants in the CNR1 gene predispose to headache with nausea in the presence of life
stress (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347942/
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26778127
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616300045
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
Social defeat leads to changes in the endocannabinoid system; an overexpression of calreticulin and motor impairment in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300328
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930003-8/abstract
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809457
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300545
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26928784
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26987678
Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological – cardiac comorbidity? (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416300318
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stress induced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Exercise as an adjunctive treatment for cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314543
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide (abst–2016) http://www.sciencedirect.com/science/article/pii/S0378427416301667
Understanding resilience: New approaches for preventing and treating PTSD (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27417856
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey  inhibitory synapses (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1113/JP272292/abstract
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616301269
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Older marijuana users: Life stressors and perceived social support (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27776245
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives (abst–2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.889
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? (abst–2016) http://link.springer.com/article/10.1007%2Fs00441-016-2544-1
Signaling pathways to and from the hypophysial pars tuberalis, an important center for
the control of seasonal rhythms (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28511899
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models (abst–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.epilepsybehavior.com/article/S1525-5050(16)30334-1/fulltext
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure (full–2017) http://www.nature.com/articles/ncomms14782
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial  orbital cortex of mice with acute stress (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553743/
The Endocannabinoid System Differentially Regulates Escape Behavior in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756047/
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol
Consumption in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777574/
2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in  cardiomyocytes (download–2017)  http://www.jbc.org/content/early/2017/03/20/jbc.M116.767384.long
Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28134998
FAAH Inhibition Produces Antidepressant-like efforts of Mice to Acute Stress via Synaptic Long-term Depression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28193523
Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28148494
Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model  of social isolation stress (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0361923016303100
Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor containing afferents in the noradrenergic nucleus locus coeruleus: implications for the  cognitive limb of the stress response (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28255675
Nutritional status dependent endocannabinoid signalling regulates the integration of rat  visceral information (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28233325
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the  Modulation of Anxiety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0006322317313574
Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis (abst–2017) http://www.sciencedirect.com/science/article/pii/S0278584616302470
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress  and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncan Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration  in Southern Peruvian Highlanders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28665150
Cannabinoids prevent the differential long-term effects of exposure to severe stress on  hippocampal- and amygdala-dependent memory and plasticity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28667676
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain  Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
Effects of cannabinoid drugs on aversive or rewarding drug-associated memory  extinction and reconsolidation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28729064
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28745306
The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event (abst–2017) http://www.sciencedirect.com/science/article/pii/S1074742717301284?via%3Dihub
Blunted stress reactivity in chronic cannabis users (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4648-z
Pharmacological challenge studies with acute psychosocial stress (abst–2017)  http://www.psyneuen-journal.com/article/S0306-4530(17)30544-9/fulltext
Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain  injury to optimize and facilitate clinical translation (abst–2017)
http://www.sciencedirect.com/science/article/pii/S014976341730088X
Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid  Mobilization in the Prelimbic Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29100630
Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress (abst–2017) http://www.psyneuen-journal.com/article/S0306-4530(17)30614-5/fulltext
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Cognitive, physical, and mental health outcomes between long-term cannabis and  tobacco users (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304628?via%3Dihub
Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid  expression of innate anxiety and excessive alcohol intake (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29071769
Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent  Patients (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29105663
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis (abst–2017) https://link.springer.com/article/10.1007%2Fs00415-017-8715-5
Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28826950
The reasons for use of cannabinoids and stimulants in patients with schizophrenia.
(links to full in English & Polish – 2018) http://psychiatriapolska.pl/261_273_S
The selective reversible FAAH inhibitor, SSR411298, restores the development of
maladaptive behaviors to acute and chronic stress in rodents. (full – 2018)
https://www.nature.com/articles/s41598-018-20895-z
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. (full – 2018)
https://www.nature.com/articles/s41398-018-0141-7
Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study. (full – 2018)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196330
Sexual orientation disparities in the co-occurrence of substance use and psychological distress: a national population-based study (2008-2015). (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862943/
Unique treatment potential of cannabidiol for the prevention of relapse to drug use:
preclinical proof of principle. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098033/
Marijuana Use Among Adults 50 Years or Older in the 21st Century. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024284/
A naturalistic examination of the perceived effects of cannabis on negative affect.
(full – 2018) https://www.jad-journal.com/article/S0165-0327(18)30310-0/fulltext
Inhibition of fatty acid amide hydrolase by PF-3845 alleviates the nitrergic and
proinflammatory response in rat hippocampus following acute stress. (full – 2018)
https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy033/4951485
Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on
mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.
(full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969305/
Risk Factors and Management of Takotsubo Cardiomyopathy. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044494/
Long-Term Stress and Concomitant Marijuana Smoke Exposure Affect Physiology,
Behavior and Adult Hippocampal Neurogenesis. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00786/full
Peripubertal stress increases play fighting at adolescence and modulates nucleus
accumbens CB1 receptor expression and mitochondrial function in the amygdala.
(full – 2018) https://www.nature.com/articles/s41398-018-0215-6
Effects of an early life experience on rat brain cannabinoid receptors in adolescence and adulthood. (full – 2018)  https://www.sciencedirect.com/science/article/pii/S2451830117300511?via%3Dihub
Marijuana Use and Hypothalamic-Pituitary-Adrenal Axis Functioning in Humans.
(full – 2018) https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00472/full
Violence Victimization, Substance Use, and Suicide Risk Among Sexual Minority High
School Students – United States, 2015-2017. (full – 2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6743a4.htm?s_cid=mm6743a4_wExploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256035/
Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness (full–2018) https://ascopubs.org/doi/full/10.1200/EDBK_209437?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
Involvement of activated brain stress responsive systems in excessive and “relapse”
alcohol drinking in rodent models: implications for therapeutics. (link to PDF – 2018)
http://jpet.aspetjournals.org/content/early/2018/04/18/jpet.117.245621.long
Stress responding in cannabis smokers as a function of trauma exposure, sex, and relapse in the human laboratory. (link to PDF – 2018)
https://www.researchgate.net/publication/322827696_Stress_responding_in_cannabis_smokers_as_a_function_of_trauma_exposure_sex_and_relapse_in_the_human_laboratory
Cannabinoids in pain medicine (abst in German & English–2018)  https://link.springer.com/article/10.1007%2Fs00482-018-0299-1
Oxidative burst and Dectin-1 triggered phagocytosis affected by Norepinephrine and
Endocannabinoids – Implications for fungal clearance under stress. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29329391
Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818300510
Trajectory Classes of Cannabis Use and Heavy Drinking among Rural African American Adolescents: Multilevel Predictors of Class Membership. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29453937
Fatty acid binding protein deletion prevents stress-induced preference for cocaine and dampens stress-induced corticosterone levels. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29457656
Effects of CB1 receptor antagonism and stress exposures in adolescence on
socioemotional behaviours, neuroendocrine stress responses, and expression of relevant proteins in the hippocampus and prefrontal cortex in rats. (abst– 2018)
https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
Association between alcoholism and the gene encoding the endocannabinoid synthesizing enzyme diacylglycerol lipase alpha in the Japanese population. (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0741832917308728?via%3Dihub
Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex. (abst – 2018)
http://www.europeanneuropsychopharmacology.com/article/S0924-977X(18)30044-0/fulltext
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0028390818301023?via%3Dihub
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29524396
Glucocorticoid-endocannabinoid uncoupling mediates fear suppression deficits after
early – Life stress. (abst – 2018)
https://www.psyneuen-journal.com/article/S0306-4530(17)31483-X/fulltext
Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review  (abst – 2018) https://www.semanticscholar.org/paper/Cannabinoid-Receptors%2C-Mental-Pain-and-Suicidal-a-Colino-HerranzHerrer/b6a2d61fe231a5dc334f6dfe97c16efb8a88221b
Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0166432818301876
Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29737034
Heavy marijuana use but not deprivation is associated with increased stressor reactivity (abst – 2018) http://psycnet.apa.org/record/2018-21052-002
The association between perceived distress tolerance and cannabis use problems,
cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0306460318304957
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 (abst – 2018) https://www.nature.com/articles/s41386-018-0064-2
The Lateral Habenula Directs Coping Styles Under Conditions of Stress Via Recruitment of the Endocannabinoid System. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29887035
The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia – a case control study. (abst – 2018)
https://www.jpain.org/article/S1526-5900(18)30197-4/fulltext
Prevalence of consumption of psychoactive substances amongst dockers. (abst – 2018) https://journals.viamedica.pl/international_maritime_health/article/view/57730
Prevalence of Substance Use among Lesbian, Gay, Bisexual, and Transgender Youth in Military Families: Findings from the California Healthy Kids Survey. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/29303404
Prevalence and Correlates of Substance Use in Homeless Youth and Young Adults.
(abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29505458
Medicinal versus Recreational Cannabis Use among Returning Veterans. (abst – 2018)
http://psycnet.apa.org/doiLanding?doi=10.1037%2Ftps0000133
Endocannabinoid system, stress and HPA axis. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30036537
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (abst – 2018)
https://www.semanticscholar.org/paper/Risks-and-Benefits-of-Marijuana-Use%3A-A-National-of-KeyhaniSteigerwald/72d1820fcad2d5c86152febf95001935b5e11c56
Dating violence victimization and substance use: The role of a serotonin transporter gene polymorphism (5HTTLPR). (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0376871618303090
Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety,
corticosterone concentrations, and contextual fear in adulthood in rats. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0736574818301758?via%3Dihub
Acute foot-shock stress decreased seizure susceptibility against pentylenetetrazole induced seizures in mice: Interaction between endogenous opioids and cannabinoids (abst – 2018) https://www.epilepsybehavior.com/article/S1525-5050(17)30777-1/fulltext
Distress tolerance and cannabis craving: The impact of laboratory-induced distress  (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30346191
Early Risk Factors for Daily Cannabis Use in Young Adults. (abst – 2018)
http://journals.sagepub.com/doi/abs/10.1177/0706743718804541?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cpab
Distress tolerance and cessation-related cannabis processes: The role of cannabis use
coping motives. (abst – 2018)  https://www.sciencedirect.com/science/article/abs/pii/S0306460318308888?via%3Dihub
Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0028390818308517?via%3Dihub
Differences in Substance Use Disparities Across Age Groups in a National Cross Sectional Survey of Lesbian, Gay, and Bisexual Adults. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434594/
The effects of trauma on brain and body: A unifying role for the midbrain periaqueductal gray. (full – 2019)  https://onlinelibrary.wiley.com/doi/full/10.1002/jnr.24447
Sex differences in stress and immune responses during confinement in Antarctica  (full–2019) https://bsd.biomedcentral.com/articles/10.1186/s13293-019-0231-0
Stress Related Shift Toward Inflammaging in Cosmonauts After Long-Duration Space
Flight (full – 2019) https://www.frontiersin.org/articles/10.3389/fphys.2019.00085/full
Stress during Lactation Induces Insulin Resistance Associated with an Increase in Type 1 Cannabinoid Receptors in Liver and Adipose Tissue. (full – 2019)
https://www.hindawi.com/journals/jnme/2019/2806519/
Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users (abst–2019) https://www.sciencedirect.com/science/article/pii/S0091305718303599?via%3Dihub
Differential Impact According to Mission’s Operational Intensity on Psychoactive
Substance Use: A Retrospective Cohort of French Male Army Service Members (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30648459
PTSD Symptom Severity, Cannabis, and Gender: A Zero-Inflated Negative Binomial
Regression Model (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30767607
Threat Responsiveness as a Function of Cannabis and Alcohol Use Disorder Severity.
(abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31170004
Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria
Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use
Disorder. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31373708
A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH
gene on anxious and depressive phenotypes. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31382124
Anandamide modulation of circadian- and stress-dependent effects on rat short-term
memory (abst–2019)  https://www.sciencedirect.com/science/article/abs/pii/S0306453018312162?via%3Dihub
Biological underpinnings from psychosocial stress towards appetite and obesity during youth: research implications towards metagenomics, epigenomics and metabolomics (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31298176
Association of CNR1 genotypes with changes in neurocognitive performance after
eighteen-month treatment in patients with first-episode psychosis. (abst – 2019)
https://www.ncbi.nlm.nih.gov/pubmed/31398679
Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like
behaviors and protein expression at hippocampal synapses in chronic unpredictable
stress-treated rats by enhancing endocannabinoid signaling. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0091305719301376?via%3Dihub
Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol
concentrations in adults with chronic PTSD. (abst – 2019)
https://www.sciencedirect.com/science/article/pii/S0301051119300110?via%3Dihub
Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30789299


STROKE*+
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459020/ 
Involvement of GluR2 up-regulation in neuroprotection by electro-acupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Time-Dependent Protection of CB2 Receptor Agonist in Stroke (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0141600
top
Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558292/
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Pre-clinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System (abst–2015) https://link.springer.com/article/10.1007%2Fs11886-015-0627-3 
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26343919
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0006291X15307270
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Endocannabinoids in Cerebrovascular Regulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865067/
Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under  Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation (full–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27021494
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408584/
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome  After Stroke (full–2016) http://stroke.ahajournals.org/content/48/1/204.long
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by  the excess microglia-mediated inflammation (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26778127
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
top
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679

Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.13613/abstract;jsessionid=0C6306A98EEF48804178DBCA7B93ECF9.f03t02
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Pharmacological hypothermia: a potential for future stroke therapy? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27320243
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449 Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305353
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Repeated Thrombosis After Synthetic Cannabinoid Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595371
Acute Effects of Synthetic Cannabinoids: Update 2015 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27715709
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28042028
CB2 cannabinoid receptors modulate HIF-1α and TIM-3 expression in a hypoxia ischemia mouse model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28253997
β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive  Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2-Mediated Pathway (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00002/full
In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke  neuroinflammation in rats: a positron emission tomography study (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0851-4
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017) http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD  oromucosal spray efficacy as an add-on therapy for post-stroke spasticity (full–2017) http://bmjopen.bmj.com/content/7/9/e016843.long
Involvement of the endocannabinoid system in the physiological response to transient  common carotid artery occlusion and reperfusion (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248520/
Ischemic stroke associated with the use of a synthetic cannabinoid (spice) (full–2017) http://www.asianjournalofpsychiatry.com/article/S1876-2018(16)30148-4/fulltext
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of  Vascular Dementia (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke  Prevention (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665427/
Strokes are possible complications of cannabinoids use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28237318
Neurological aspects of medical use of cannabidiol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28412918
Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in  n-acylethanolamines in mouse brain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28488728
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of  endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation induced apoptosis through inhibiting anandamide inactivation system (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300123
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor  URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion  model by blocking NF-κB pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825114
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and  the ugly (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28905873
Activation of cannabinoid receptor 1 is involved in protection against mitochondrial  dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29045576
Cannabis Smoking and Cardiovascular Health: It’s Complicated (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548223
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous  system diseases (abst–2017)  http://www.eurekaselect.com/152965/article
Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two  models of ischemia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29288767
Ischemic stroke associated with the use of a synthetic cannabinoid (spice) (link to PDF–2017)  https://www.researchgate.net/publication/309622034_Ischemic_stroke_associated_with_the_use_of_a_Synthetic_Cannabinoid_spice
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. (link to PDF – 2017)  https://www.researchgate.net/publication/319703443_Cardiovascular_effects_of_marijuana_and_synthetic_cannabinoids_The_good_the_bad_and_the_ugly
Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic
review of case reports (abst in English, full in Spanish – 2017)
http://www.elsevier.es/es-revista-neurologia-295-avance-resumen-ictus-consumo-cannabis-pacientes-sin-S0213485317303626
Strokes are possible complications of cannabinoids use. (abst – 2017)
https://www.epilepsybehavior.com/article/S1525-5050(16)30735-1/fulltext
Neurological aspects of medical use of cannabidiol. (abst – 2017)
http://www.eurekaselect.com/151582/article
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of
endocannabinoid system modulation. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28497982
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivationinduced apoptosis through inhibiting anandamide inactivation system (abst–2017) http://www.sciencedirect.com/science/article/pii/S0168010217300123
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor
URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion
model by blocking NF-κB pathways (abst–2017)  https://www.semanticscholar.org/paper/Cannabinoid-receptor-agonist-WIN55%2C212-2-and-fatty-SuWu/8003ccdbade2b9415b8a4410caf2f901fbecb49eCannabis Smoking and Cardiovascular Health: It’s Complicated. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28548223
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous
system diseases. (abst – 2017)
http://www.eurekaselect.com/152965/article
Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion (full–2018) https://lipidworld.biomedcentral.com/articles/10.1186/s12944-018-0661-4
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury (full–2018)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1166-9
Intracerebral Hemorrhage with Multiple Intracranial Arterial Stenoses in a Synthetic
Cannabinoid “Spice” User. (full – 2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898148/
Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats (full–2018)
https://www.physiology.org/doi/10.1152/ajpheart.00299.2017
A Systematic Review of the Complex Effects of Cannabinoids on Cerebral and
Peripheral Circulation in Animal Models. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphys.2018.00622/full
Octadecylpropyl Sulfamide Reduces Neurodegeneration and Restores the Memory
Deficits Induced by Hypoxia-Ischemia in Mice. (full – 2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00376/full
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871676/
Acute carotid thrombosis and ischemic stroke following overdose of the synthetic
cannabinoid K2 in a previously healthy young adult male. (full – 2018)
https://www.sciencedirect.com/science/article/pii/S193004331830027X?via%3Dihub
Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. (full – 2018)
https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-018-0395-2
Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein
Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery
Occlusion and Reperfusion (link to full–2018) http://www.mdpi.com/1422-0067/19/2/426
Association and Clinical Outcomes of Marijuana in Patients with Intracerebral
Hemorrhage. (link to PDF–2018)
https://www.researchgate.net/publication/327506574_Association_and_Clinical_Outcomes_of_Marijuana_in_Patients_with_Intracerebral_Hemorrhage
Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents (click “sagepub” for download – 2018)https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Longterm+depression+induced+by+endogenous+cannabinoids+produces+neuroprotection+via+astroglial+CB1R+after+stroke+in+rodents.
&btnG=
Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke. (1st page – 2018)
https://www.deepdyve.com/lp/wolters-kluwer-health/neuroprotective-effects-of-magl-monoacylglycerol-lipase-inhibitors-inGN0Y423b4C?impressionId=5b623c0c1d67d&i_medium=docview&i_campaign=recommendations&i_source=recommendations
Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29880579
Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0890623818301357?via%3Dihub
JZL184, as a monoacylglycerol lipase inhibitor, down-regulates inflammation in a
cannabinoid pathway dependent manner. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S075333221735014X
A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats. (abst 2018)
https://www.sciencedirect.com/science/article/pii/S0006899318303330?via%3Dihub
The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on
cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0165178117314798
Monoacylglycerol Lipase Inhibitor is Safe when Combined with Delayed r-tPA
Administration in Treatment of Stroke. (abst – 2018)
https://link.springer.com/article/10.1007/s10753-018-0848-x
Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia (abst – 2018) https://link.springer.com/article/10.1007%2Fs00213-018-4982-9
Cannabinoid receptor 2 agonist attenuates blood-brain barrier damage in a rat model of intracerebral hemorrhage by activating the Rac1 pathway. (abst – 2018)
https://www.spandidos-publications.com/ijmm/42/5/2914
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion
Comorbidities in Middle-Aged Rats. (abst – 2018)
https://link.springer.com/article/10.1007%2Fs12640-018-9972-5
Review of the many faces of synthetic cannabinoid toxicities. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/
Cannabis and Cannabinoid Biology in Stroke. (1st page – 2019)
https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.118.023587
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review (abst–2019)  https://journals.sagepub.com/doi/abs/10.1177/1049909119850807?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ajhb


STURGE-WEBER SYNDROME
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28454984


STUTTERING+
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve  Severe Vocal Blocking Tics in Two Patients (full – 2017)
http://www.mdpi.com/1422-0067/18/8/1739/htm


SUICIDE+
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26331953
Endocannabinoids and Mental Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
top
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx

Dose of Reality: The Effect of State Marijuana Legalizations (report–2016) http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full
Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26890319
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314752
Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed  cannabinoids (full–2017) http://casereports.bmj.com/content/2017/bcr-2017-222059.long
New challenges in toxicology of new psychoactive substances exemplified by fatal cases  after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MSMS in blood (full in Polish & English-2017)  https://www.termedia.pl/Journal/-82/Artykul-31005
Associations between substance use disorders and suicide or suicide attempts in people  with mental illness: A Danish nationwide, prospective, register-based study of patients  diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality  disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
Cannabis use and the course and outcome of major depressive disorder: A population  based longitudinal study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31187-8/abstract
Acute Substance Use as a Warning Sign for Suicide Attempts: A Case-Crossover  Examination of the 48 Hours Prior to a Recent Suicide Attempt (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28682530
Synthetic Cannabis Analogues and Suicidal Behavior: Case Report (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796120
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext
The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. (full – 2018)
https://bsd.biomedcentral.com/articles/10.1186/s13293-018-0182-x
Violence Victimization, Substance Use, and Suicide Risk Among Sexual Minority High
School Students – United States, 2015-2017. (full – 2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6743a4.htm?s_cid=mm6743a4_w
Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200442/
Mental Health Issues and Substance Use in the United States: Pulling the Power Levers (full – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30406713
Sleep Disturbances, Psychosocial Difficulties and Health Risk Behaviour in 16,781
Dutch Adolescents (full–2018) https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1876285918301232?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1876285918301232%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F
Substance Use and Suicide in Pacific Islander, American Indian, and Multiracial Youth (link to PDF – 2018)  https://www.researchgate.net/publication/324502721_Substance_Use_and_Suicide_in_Pacific_Islander_American_Indian_and_Multiracial_Youth
Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims. (abst – 2018)
https://www.semanticscholar.org/paper/Alterations-in-Gene-and-Protein-Expression-of-CB2-Garc%C3%ADa-Guti%C3%A9rrezNavarrete/c30e5f1199356f223beba358f2fa0a90b2bac2ae
Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review  (abst–2018) https://www.semanticscholar.org/paper/Cannabinoid-Receptors%2C-Mental-Pain-and-Suicidal-a-Colino-HerranzHerrer/b6a2d61fe231a5dc334f6dfe97c16efb8a88221b
Is cannabis a risk factor for suicide attempts in men and women with psychotic illness? (abst – 2018) https://link.springer.com/article/10.1007%2Fs00213-018-4924-6
Psychosis and synthetic cannabinoids. (abst – 2018)
https://www.sciencedirect.com/science/article/pii/S0165178117314312?via%3Dihub
Sex Differences in the Association Between Cannabis Use and Suicidal Ideation and
Attempts, Depression, and Psychological Distress Among Canadians. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30260680
Supporting Transgender and Gender Diverse Youth: Protection Against Emotional
Distress and Substance Use. (abst – 2018)
https://www.ncbi.nlm.nih.gov/pubmed/30344037
From Substance Use Disorders in Life to Autopsy Findings: A Combined Case-Record
and Medico-Legal Study. (full – 2019)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427694/
Depressive Symptoms and Suicidality in Adolescents Using e-Cigarettes and Marijuana: A Secondary Data Analysis From the Youth Risk Behavior Survey. (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30688723
Medical Marijuana Laws and Suicide (abst–2019)  https://www.ncbi.nlm.nih.gov/pubmed/31079575


SURFER’S EYE/PTERYGIUM
Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium (link to PDF – 2017)
https://www.spandidos-publications.com/10.3892/mmr.2017.7246


SYSTEMIC MASTOCYTOSIS
Systemic mastocytosis and medical marijuana (case report-undated) http://cannabisclinicians.org/view-all-case-reports/entry/645/


Updated 7 October, 2019